Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
17 January 2026
237 mins read

Stock Market Today 17.01.2026


LIVEMarkets rolling coverageStarted: Updated:

TransDigm Group still undervalued after share-price momentum, but leverage risk weighs on upside

January 17, 2026, 11:51 PM EST. TransDigm Group (TDG) has posted recent share-price gains and upward momentum, with a 1-month return of about 13.56% and a 1-year return near 15.65%, according to the analysis. Revenue of $8.83 billion and net income of $1.87 billion were reported, while the stock traded around $1,450. A fair value around $1,586 implies roughly 9-10% upside, but the current P/E of 43.8x sits above aerospace and defense group averages. Analysts expect revenue to grow about 8% annually over the next three years, signaling potential for higher margins if profitability improves. However, high leverage and reliance on aftermarket demand pose risks if sector conditions deteriorate. Investors should weigh growth and valuation assumptions against these risks.

Elevance Health Valuation Gap Persists, DCF Signals Undervalued

January 17, 2026, 11:46 PM EST. Elevance Health trades at $374.87 a share, with mixed momentum: up 0.5% in 7 days, 10% in 30 days, and a 5.8% YTD gain. Longer horizons show declines: 0.8% over 1 year, 18.2% over 3 years, and 27.7% over 5. Simply Wall St's 6-point checklist rates the stock 5/6, signaling it is broadly undervalued. A two-stage Free Cash Flow to Equity model, using trailing FCF of about $3.58 billion, implies an intrinsic value near $1,011.50 per share, about 62.9% above the current price. The P/E approach is described as a quick valuation lens, but the excerpt cuts off before a conclusion, leaving the gap between price and earnings less clear in this piece.

Is BlackRock pricing in too much growth after multi-year gains?

January 17, 2026, 11:41 PM EST. BlackRock trades near $1,163.17, with seven-day returns around 7% and a year-to-date gain near 7%, extending to roughly 68% over three years and 78% over five. The article questions whether the price already prices in growth. Simply Wall St rates the stock 1/6 on valuation. Approach 1, the Excess Returns method, starts from a book value per share of $357.90 and a stable value of $383.66, with a stable EPS of $64.75 and an ROE of 16.88%. Using a $31.74 cost of equity yields an implied excess of $33.01 and an intrinsic value of about $1,042.08, suggesting the stock is about 11.6% overvalued at $1,163.17. Approach 2 uses P/E to relate current earnings to price, noting growth and risk affect the fair multiple.

Commercial Metals (CMC) Valuation Signals Undervaluation After Five-Year Rally

January 17, 2026, 11:36 PM EST. Commercial Metals (CMC) closed at $74.42, up 2.7% in a week and with a five-year run of about 270.6%. A valuation framework rates it 5/6 for potential undervaluation. The DCF analysis yields an intrinsic value around $118.74 per share, implying the stock trades at roughly a 37.3% discount to fair value. The model uses a two-stage Free Cash Flow to Equity forecast, with last twelve months' FCF near $271.2 million and projections to 2028 of $817.95 million. Investors weigh this against other methods like P/E as earnings trajectories and risk influence the normal multiple. The outcome: a market price that may be shy of its fundamental value, though peers' performance matters.

ATI valuation after multi-period rally

January 17, 2026, 11:31 PM EST. ATI shares have rallied, prompting a fresh valuation check. The stock closed at $124.35 after a 90-day return near 52.8% and a 1-year total shareholder return around 117%. Simply Wall St's narrative assigns a fair value of $118.25, suggesting the price sits a touch above that estimate. Valuation rests on a 7.80% discount rate and assumptions for growth and margins. The report highlights higher margins in High Performance Materials & Components, approaching 24%, and stronger EBITDA and free cash flow, supporting an intrinsic value case. However, risk factors include reliance on a small set of aerospace customers and ongoing heavy capital spending. The stock trades at about 38x P/E, below some peers/industry averages but above its own fair ratio of 32.8x, signaling mixed signals.

Equinix Seen Undervalued by DCF, Yet Mixed Signals Persist

January 17, 2026, 11:27 PM EST.Equinix trades around $801.78, with a mixed path: up 0.2% in the last week, 7.8% in 30 days, 4.9% year-to-date, but down 10.4% over the past year. The backdrop remains strong for data-center and digital-infrastructure assets as investors compare colo and interconnection assets with real estate and tech peers. The stock scores 2/6 on our valuation checks, signaling mixed signals. In a Discounted Cash Flow (DCF) model, Adjusted Funds From Operations are projected higher, producing an intrinsic value of about $1,288.84 per share and implying the current price is roughly 37.8% below fair value. A second method-P/E considerations-begins to frame how growth and risk shape what investors pay for earnings.

Is It Time to Reconsider Clorox (CLX) After a Multiyear Slump?

January 17, 2026, 11:22 PM EST. Clorox (CLX) trades near $109.98 after a rough stretch; the stock is down 28.8% in the last year and 36.4% over five years. In the week it rose about 3.6%, and over 30 days about 8.3%. The backdrop: changing consumer habits and cost pressures weighing on cash flow. Our valuation framework scores Clorox 3 of 6. Approach 1, a Discounted Cash Flow (DCF) model, puts intrinsic value at about $213.43 per share, implying a roughly 48.5% discount to the current price. Approach 2: Price-to-Earnings (P/E) links the stock to earnings, noting that a "normal" P/E depends on growth and risk. Together, the methods present a mixed view on fair value.

Snap undervalued after extended weakness as DCF points to near $16 fair value

January 17, 2026, 11:17 PM EST. Snap's stock closed at $7.53, after an 8.3% drop over the past week and a broader run of declines over several horizons. The 6-point valuation check yields 4/6. A two-stage Discounted Cash Flow model places the stock's intrinsic value at about $15.98 per share, suggesting it is undervalued by roughly 53% versus the price. In the price-to-sales lens, Snap trades at a P/S ratio of 2.24x, above the industry average of 1.06x but below the peer group average of 3.09x. Those multiples reflect higher growth expectations but persistent risk. The analysis uses a FCF-to-equity framework, with TTM FCF around $390.4 million and longer-term projections to 2030 of about $1.55 billion.

Tencent Holdings appears undervalued after 64% one-year gain, according to DCF valuation

January 17, 2026, 11:12 PM EST. Tencent Holdings (SEHK:700) trades at HK$617.50 after a 64% gain in the last year. Simply Wall St's checks flag the stock as undervalued on a two-stage Discounted Cash Flow (DCF) basis, with an intrinsic value around HK$897.25 per share, about 31% higher than the current price. The model uses projected free cash flow rising from about CN¥201.2b to CN¥403.7b by 2029. The analysis notes Tencent's role as a major Hong Kong-listed tech and media name, amid shifting sentiment toward large China-exposed platforms. Short-term moves show gains over 7 and 30 days, while longer horizons remain mixed. The piece positions cash-flow valuation alongside earnings multiples, stressing risk factors from regulatory and market conditions in China.

Enlight Renewable Energy valuation under scrutiny after momentum surge (TASE: ENLT)

January 17, 2026, 11:07 PM EST. Enlight Renewable Energy (TASE: ENLT) has drawn fresh attention after a momentum stretch. The stock rose 21.4% in the last month and 40.6% over three months. In the latest frame, the Israeli-listed developer traded at ₪160.40 and reported revenue of $457.756 million with net income of $122.997 million. Investors note a 6.9% year-to-date return but a 164.6% total return over the past year, signaling a reassessment of growth and risk. The price-to-earnings ratio, or P/E, compares share price to earnings per share and stood at 54.8x-well above the Asian renewables average of 16x and peer average of 44.5x-implying a valuation premium for continued expansion, with less cushion if growth slows. Risks to watch include project delays and cost pressure.

Butterfly Network Valuation After NYSE Warrant Delisting and Revenue Guidance

January 17, 2026, 11:03 PM EST. Butterfly Network (BFLY) is back in focus after the NYSE moved to delist its publicly traded warrants. Its Class A common stock continues trading, and fresh revenue guidance has drawn fresh attention. At US$4.16, the stock posted a 90-day return of 76.27% and a 30-day gain of 16.85%; 1-year TSR stood at 13.35% and 3-year TSR at 55.81%, signaling renewed momentum after the warrant delisting news and guidance. A rough fair value assessment near US$4.19 suggests current prices are in line with near-term growth expectations. Risks include stalled enterprise deals, weaker software renewals, and ongoing heavy R&D spend that could pressure margins. The stock trades at a P/S ratio about 11.9x, well above the medical equipment peer group, prompting questions about the growth premium.

J&T Global Express valuation shows 54% discount amid volatility

January 17, 2026, 10:58 PM EST.J&T Global Express (SEHK:1519) faced mixed short-term moves, with a 3.6% one-day decline and a 5% drop over the past week. The stock has logged positive momentum in recent months: 30-day return 9.3%, 90-day 15.15%, and a 1-year total shareholder return of 80.09%. At HK$11.40 per share, the price implies a roughly 54% discount to an intrinsic value estimate, with a fair value of HK$11.51 unchanged. The SWS DCF model puts fair value at HK$24.77, indicating a wider gap to the current price target. Risks include ongoing price competition in China affecting EBIT and the capital intensity of expansion that could strain free cash flow. Investors should weigh whether the growth outlook justifies the discount or if the market has already priced in risks.

Textron Still Attractively Priced After Multi-Year Rally, Valuation Mixed

January 17, 2026, 10:54 PM EST.Textron's stock closed at $94.23, with 7-day, 30-day, and year-to-date gains of 0.4%, 5.3%, and 8.2%, respectively. Over 1, 3, and 5 years the returns are 19.2%, 39.3%, and 90.5%. The stock trades with a valuation score of 5 out of 6. A DCF model using a 2-stage Free Cash Flow to Equity framework yields an intrinsic value of $135.66 per share, implying about a 30.5% discount to the market price and suggesting the stock is undervalued on this basis. The P/E ratio stands at 20.06x, reflecting expectations for continued earnings. Textron is a diversified industrial and aerospace company, with investors watching aircraft, defense, and industrial segments as part of longer-term portfolios.

ADX appears ~50% undervalued on Excess Returns model

January 17, 2026, 10:43 PM EST. ADX trades around US$23.12 after a multi-year run. Over 1 year, 3 years and 5 years, returns are 20.5%, 103.5%, and 114.1%. Simply Wall St assigns a valuation score of 4/6 amid ongoing market focus on fund pricing. Using an Excess Returns framework, with a book value of US$23.35 per share, stable EPS US$3.62, ROE 17.62% and a cost of equity US$1.98, the implied intrinsic value is about US$46.35. That suggests the stock is around 50.1% undervalued versus the current price. The report frames valuation around discounts or premiums to underlying portfolios and notes the P/E ratio as a simple yardstick.

Compass Minerals rebound may be overvalued, DCF suggests

January 17, 2026, 10:38 PM EST. Compass Minerals International's stock at $23.29 places a strong rebound alongside a cautious valuation. The article notes a 7-day return of 2.5%, 30-day 22.9%, YTD 17.3%, one-year 63.9%, but declines over multi-year frames (-47% over 3 years, -59.7% over 5). The firm scores 2/6 on its valuation checks, indicating potential overvaluation. The primary framework is a Discounted Cash Flow (DCF) model using a 2-stage Free Cash Flow to Equity (FCFE) approach. It estimates a last-twelve-month FCF of about $79.7 million; projected 2026 FCF $55.5m, 2027 $47.7m, then $42.1m by 2035 (discounted to $15.6m). The resulting implied intrinsic value is about $11.78 per share, implying CMP is about 97.7% overvalued at the current price. Also notes the P/S ratio as a reference.

KOSE Holdings (TSE:4922) Stock Hits Lows on Weak ROE, Earnings Decline

January 17, 2026, 10:27 PM EST. KOSE Holdings' stock has fallen 7.9% in the last three months, prompting a look at the company's fundamentals. The key finding: return on equity (ROE), a measure of how effectively profits are reinvested, sits at 3.0% for the trailing twelve months to September 2025, based on JP¥8.7 billion net profit and JP¥290 billion in shareholder equity. This ROE lags the industry average of 6.6% and aligns with a five-year earnings decline of 9.8%. Analysts note capital allocation and payout policy can affect growth; a lower ROE suggests limited scope to lift profits vs peers. By comparison, the broader industry has grown earnings around 3.8% over the same span, widening KOSE's relative gap.

Lloyds Enterprises shares fall 25% as high P/E raises caution (NSE:LLOYDPP)

January 17, 2026, 10:22 PM EST. Lloyds Enterprises Limited NSEI:LLOYDPP has fallen about 25% in the last month, erasing a year of gains and returning to levels from a year ago. The stock trades at a P/E of 31.6x, above the Indian market average around 24x and well above sub-13x multiples. The valuation may be hard to justify without stronger momentum, though recent results show a surge in EPS. Last year's EPS rose 183%, with a three-year gain of 59%, placing Lloyds ahead on growth. Still, a sector-wide forecast of roughly 25% earnings growth suggests the stock's P/E is lofty relative to near-term prospects. Investors should weigh whether the high multiple is supported by durable earnings.

Smart Reads of the Week: Singapore Blue Chips, Dividends, and Top REITs for 2026

January 17, 2026, 10:14 PM EST. Singapore's market enters 2026 with renewed focus on blue chips, dividend sustainability, and value after rallies. This week's Smart Reads weighs whether DBS, Singtel, and ST Engineering still offer value, compares bank dividends after recent moves with a look at UOB vs OCBC, and highlights blue chips positioned for the year ahead. It also examines how MAS's S$5 billion equity scheme could lift dividends, which REITs stand out in 2026, and income stocks delivering yields above 5% that help beat inflation. The package also probes Singtel's turnaround and how investors can navigate the 2026 backdrop.

James Hardie plant closures to drive cost savings as AZEK synergies factor into earnings

January 17, 2026, 10:09 PM EST.James Hardie Industries will close its Fontana, California and Summerville, South Carolina plants within 60 days, shifting production under the Hardie Operating System to other facilities. The company expects about US$25 million in annualized cost savings from fiscal Q1 2027, while reaffirming its guidance for the third quarter and full year fiscal 2026. The move follows the mid-2025 AZEK acquisition, which reshaped scale, product mix and synergies. Plant closures, savings and the Hardie Operating System sit alongside AZEK synergies as key levers for earnings, even as investors weigh integration risk and higher leverage amid weaker volumes.

SiriusPoint near fair value after three-year rally; Excess Returns model shows modest undervaluation

January 17, 2026, 10:04 PM EST.SiriusPoint (SPNT) last traded at $20.00, with a 7-day decline of 0.5%, a 30-day decline of 8.9%, and a year-to-date decline of 5.1%. The 1-year return is +33.4% and the 3-year gain is about 3x. Simply Wall St assigns a valuation score of 3 out of 6, indicating it is undervalued on about half the checks. The Excess Returns model anchors value on the balance sheet-book value and a steady ROE rather than year-by-year cash flows-and yields an intrinsic value around $21.42 per share, or roughly 6.6% undervalued versus the current price. Overall, the valuation sits ABOUT RIGHT for now, subject to inputs that can move quickly.

Global Health Limited (NSE: MEDANTA) stock weakens as ROE signals earnings potential

January 17, 2026, 10:00 PM EST. Global Health Limited's stock has fallen about 17% over the past three months. Yet, the company's trailing ROE of 15% for the year to September 2025 sits above the industry average of 11% and supports a narrative of efficient capital use. Net income growth has run about 30% over the last five years, outpacing the industry's 25% pace. The analysis notes a low payout ratio and tight management that could aid reinvestment, fueling future earnings growth. The question for investors is whether this strength is already reflected in the price, given the recent weakness. Valuation measures are cited as signposts, with buyers weighing whether the earnings trajectory and capital efficiency justify the current multiple.

NNN REIT seen undervalued after multi-year rally; DCF implies ~45% upside

January 17, 2026, 9:56 PM EST. NNN REIT has posted multi-year stock gains and remains in focus for income-focused investors. The shares show 7-day, 30-day, YTD, 1-year and 5-year gains; market attention centers on its triple-net lease structure and how it affects income stability across rate regimes. A valuation check by Simply Wall St flags a value score of 5 on a 6-point checklist. Using a two-stage DCF model based on adjusted funds from operations, the latest twelve-month FFO is $616.6 million; projected FCF for 2028 is $753.1 million, yielding an implied intrinsic value around $77.67 per share, suggesting the stock is undervalued by about 45% versus that model. A second approach, P/E, is noted but not completed in the material.

Tokyo Koki shares jump 27% on momentum; P/S aligns with peers amid steady revenue growth

January 17, 2026, 9:51 PM EST. Tokyo Koki Co. Ltd. (TSE:7719) posted a 27% stock advance in the last month, with a 91% gain over 12 months. The shares sit at a P/S of about 0.6x, below but close to the industry median around 0.8x, a metric investors say shouldn't be read in isolation. Revenue momentum remains strong: Revenue rose about 36% in the past year, and 26% above three years ago. The market appears to expect earnings and revenue growth to moderate, keeping the P/S near peers. Industry forecasts for expansion around 7.2% next year echo Tokyo Koki's recent trajectory. The stock's recent momentum is noted, but analysts warn against overreliance on the P/S ratio alone as a gauge of value.

V-cube climbs 39% as growth stalls; P/S signals muted revenue prospects

January 17, 2026, 9:46 PM EST. V-cube, Inc. (TSE:3681) gained 39% in the past month, extending a shaky spell, yet the stock is down 21% over the past 12 months. The rebound comes as revenue trends worsen: last year's revenue fell 8.3%, and three-year revenue is down about 18%. The stock trades at a P/S ratio (price-to-sales) of roughly 0.4x, below many peers in Japan's Telecom sector where the median is above 1x. While a lower P/S can reflect weaker growth, there are no published analyst forecasts for V-cube in our data. Industry forecasts expect sector revenue to grow about 3.6% next year, setting a hurdle if V-cube's top line does not improve. In short, the market prices in subdued growth even as shares rally.

BEL ownership: State Holds Majority Stake; Institutions 28%

January 17, 2026, 9:41 PM EST. Bharat Electronics Limited (NSE: BEL) shows state control, with roughly half of shares held by a government-related holder, making the state the controlling shareholder. India is the largest holder, with about 51-52% of shares outstanding. Institutions own about 28% of BEL, while Nippon Life India Asset Management (~2.8%) and Kotak Mahindra Asset Management (~2.5%) are significant minority holders. The ownership mix implies government influence over governance decisions, alongside external validation from institutional investors. Large shifts by a major holder could move the stock, even as analysts cover the name and track earnings and forecasts. BEL faces risk-reward shaped by policy directions and public-sector priorities.

Elecon Engineering on watchlist after 3-year EPS growth; insider stake aligns

January 17, 2026, 9:36 PM EST. Elecon Engineering (NSE: ELECON) is attracting attention as a potential watchlist candidate after reporting 3-year EPS growth of about 31% per year. The company has seen revenue expansion even as EBIT margins declined last year, suggesting margin stabilization could sustain top-line gains for shareholders. Analysts have forecasts for future profits, with earnings and revenue history highlighted. Insiders own a substantial stake, valued at roughly ₹5.9 billion, aligning their interests with public shareholders and providing incentive to push the business forward. The mix of growing earnings, rising revenue, and insider alignment sits against a backdrop where investors typically favor profitable firms. If margins stabilize, the ongoing growth could reward patient investors.

Allocating $2,500 on the TSX: Canadian Utilities and Kinross Gold

January 17, 2026, 9:22 PM EST. Investors splitting $2,500 into tranches seek a defensive base amid uncertain economics. Canadian Utilities (CU) offers a 54-year dividend-growth track record and a 4.26% yield at about $43.28 a share. The stock derives roughly 90% of cash flow from regulated utilities, acting as a bond proxy in equities. Growth plans center on the Yellowhead Pipeline and CETO, with a 2025-2027 regulated-investment program of about $6.1 billion. Kinross Gold (K) trades near $46.30, with a 0.67% dividend that has grown about 17% annually, and a 192% total return in 2025. With record gold prices in early 2026, these names can serve as hedges against inflation and geopolitics as you deploy $2,500.

Q3 results, trade deals, and oil drift set top five triggers for Indian equities this week

January 17, 2026, 9:21 PM EST. Indian equity benchmarks ended a two-session pullback on Friday, led by IT stocks and banking shares. The Sensex rose 188 points to 83,570.35, while the Nifty 50 gained 29 points to 25,694.35, with Infosys lifting sentiment after upgrading its revenue outlook. Ahead of the week's earnings blitz, the market remains cautious but stock-specific, with lenders in focus as ICICI Bank and HDFC Bank post results. A slate of December-quarter earnings from IRFC, Eternal (Zomato), InterGlobe Aviation, BHEL, Coforge, JSW Steel, BPCL, and Cipla is due. Globally, traders monitor the India-EU trade agreement expected later this month and evolving U.S.-Iran rhetoric that shapes oil and risk sentiment. The near-term view remains guarded, favoring selective ideas over broad moves, driven by earnings, trade signals, and geopolitics.

Is Ziff Davis (ZD) undervalued after DCF valuation

January 17, 2026, 9:08 PM EST. Ziff Davis shares closed at $37.48, with a year-to-date gain but steep declines over 1 year and 3 years. This piece weighs whether the stock is a value opportunity or a name to avoid at current levels. A Simply Wall St. DCF valuation yields an intrinsic value of about $105.82 per share, implying the stock trades at a roughly 64% discount to today's price. The result frames concern about growth from its digital media assets amid higher interest rates. Trailing returns show a 31.8% drop over the last year and a 56.1% fall over three years. Investors should compare to peers, assess risk tolerance, and decide whether cash-flow prospects justify a larger multiple or continued weakness.

Lumen Technologies valuation check after price momentum

January 17, 2026, 9:07 PM EST. Lumen Technologies (LUMN) has drawn investor attention after a year of volatile price moves. A 5.4% one-day gain and a 25.4% rally over 90 days underscore short-term momentum, even as a 56.4% one-year total return contrasts with a negative five-year track record. The stock trades at an intrinsic premium to current forecasts and sits above the average analyst target, prompting questions about upside versus already priced-in growth. A rival view via a DCF model yields a fair value of $6.77 per share, below the current $8.65 price and also under the narrative fair value of $7.23. Risks remain: legacy revenue declines, a sizable debt load, and the pace of cash flow repair. Long-term potential rests on AI-driven network infrastructure and Platform Connectivity Fiber contracts with hyperscalers.

Lumen Q4 2025 earnings boost investor transparency as stock climbs 7.37%

January 17, 2026, 9:06 PM EST. Lumen Technologies' stock rose 7.37% on Jan. 15, 2026, buoyed by positive sentiment. The market is eyeing the forthcoming Q4 2025 earnings release on Feb. 3, 2026, a move tied to the company's emphasis on transparency and investor clarity. Amendments to tender offers lifted the aggregate maximum cap and eased terms, signaling debt-management agility. The company also raised senior notes to $650 million, backed by subsidiary guarantees, expanding financing options. Key metrics show an EBITDA margin of 20.4% is positive, but pre-tax and net profitability remain negative. Enterprise value sits at $23.96 billion with a price-to-sales ratio of 0.66 and a negative P/E; liquidity is solid, with a current ratio of 2.2. The moves suggest strategic flexibility, though profitability pressures persist and investors will scrutinize the upcoming earnings.

Lumen to publish Q4 2025 results, host earnings call Feb. 3

January 17, 2026, 9:05 PM EST. Lumen Technologies (NYSE: LUMN) will publish its fourth-quarter and full-year 2025 results after the market close on Feb. 3, 2026. A live earnings conference call will follow at 5:00 p.m. ET, with a broadcast on the company's Investor Relations site. Additional materials, including the earnings release and investor presentation, will be posted on Lumen's site. The company describes itself as the trusted network for AI, connecting people, data and applications across metro, long-haul and edge services. Media and investor contacts are listed on the release.

XRF Scientific (ASX:XRF) posts 758% five-year TSR; dividends drive returns

January 17, 2026, 8:55 PM EST. Investors in XRF Scientific (ASX:XRF) have seen standout returns over five years. The stock's price has risen about 641%, while the broader five-year total shareholder return (TSR) runs 758% when including reinvested dividends. The last 12 months delivered about 26% TSR, aided by dividends. In the most recent month, the share price gained 8.0% as market peers rose roughly 4.2%. Over five years, earnings per share (EPS) grew 26% per year, outpaced by a 49% annual rise in the share price, suggesting investors have priced in earnings growth and other factors. Dividends largely explain the TSR excess. The company has faced questions about whether growth will continue; some investors may feel they missed the opportunity, but the business could still be in play.

CNA Financial: Valuation Signals Undervaluation Amid Mixed Returns and Sector Scrutiny

January 17, 2026, 8:54 PM EST. CNA Financial trades near $46.38 as investors weigh value against sector headwinds. The stock posted mixed returns: 0.1% weekly move, -2.6% over 30 days, -1.0% year to date, +2.9% over the past year, and multi-year gains. Sector scrutiny around underwriting conditions and capital strength has kept CNA on investors' radar. In Simply Wall St. valuations, CNA scores 5 of 6 on a valuation check. The Excess Returns model, using a book value base of $41.83 and a stable $36.46, pegs stable EPS of $3.54 with ROE of 9.71% and cost of equity $2.54. It yields an excess $1.00 per share and an intrinsic value of $63.65, implying about 27.1% undervaluation versus the current price. Investors watch the P/E lens, too.

Fubo buys back US$140.2M of 2026 notes funded by Disney loan; liquidity and earnings in focus

January 17, 2026, 8:53 PM EST. Fubo (FUBO) repurchased US$140.2 million of its 2026 convertible notes, financed by a US$145 million Disney affiliate loan. The move eases the 2026 debt wall and lowers near-term refinancing risk ahead of February 27, 2026 earnings. Liquidity remains tight: current ratio 0.69, working capital about −US$176.9 million, debt/equity 0.93, net debt/EBITDA 0.54, and negative interest coverage at −4.84. Final tallies, pricing, and any dilution or covenants will depend on filings. Equity impact: large note buyback reduces potential future dilution; specifics on equity consideration are not yet public. Trading around US$2.58, with 50- and 200-day averages at US$3.02 and US$3.37; RSI 32.7, CCI −129; support near US$2.44, resistance US$2.83; ADX 36, volume 11.1m vs 14.1m avg. Canadian investors face FX and non-dividend implications; review account type and positioning.

FuboTV valuation reassessment: fair value around $4.50 as shares hover near $2.50

January 17, 2026, 8:52 PM EST. FuboTV (FUBO) trades near $2.50 after renewed scrutiny of user growth, profitability and capital burn. The stock has fallen 11.97% in 30 days and 34.73% in 90 days, after a 3-year total shareholder return of 32.28%. A rough fair value sits around $4.50, suggesting the stock could be undervalued if growth and margin drivers materialize. The bear case points to subscriber declines and ongoing cash burn; the bull case hinges on stronger ad economics, higher engagement from personalized features, and a path to profitability. Analysts and investors compare fuboTV with other live-content peers, weighing insider ownership and revenue mix as potential catalysts. Risks to the narrative include churn, funding pressures and content costs; readers should test the thesis against fresh data.

Q3 Media Earnings: fuboTV Leads as Group Beats Estimates

January 17, 2026, 8:51 PM EST. Q3 media earnings show a resilient group. Across seven tracked names, revenue beat consensus by 2.1% and shares rose an average 6.2% after results. The standout performer was fuboTV. The live-sports streamer reported revenue of $377.2 million, down 2.3% year over year but above estimates by 4.9%, with a beat on EPS and EBITDA. The stock has fallen about 28.9% from the report and trades near $2.69. In contrast, Warner Music Group posted $1.87 billion in revenue, up 14.6% YoY and well above expectations by 10.8%. Its stock rose about 1.2% to around $30.88. Among peers, Warner Bros. Discovery delivered $9.05 billion of revenue, down 6% YoY and missing content revenue estimates by 1.9%, though adjusted operating income beat estimates; the stock gained 24.5% since the print, near $28.52.

FuboTV trades at $2.61; P/E signals potential undervaluation versus peers

January 17, 2026, 8:50 PM EST. FuboTV Inc. trades at $2.61, up 1.16% in the session. The stock has risen 4.20% in the past month but is down 28.53% over the last year. The P/E ratio sits below the Interactive Media & Services industry average of 22.33, a sign some investors consider undervaluation. But a low P/E can also reflect weaker growth prospects or financial risk, so it should be used with caution alongside earnings trends, industry dynamics and qualitative factors. Data from Benzinga APIs.

Rollins (ROL) valuation under scrutiny after strong multi-year rally

January 17, 2026, 8:36 PM EST. Rollins is trading around $62.73 a share, with recent returns of 3.4% in 7 days, 4.1% in 30 days, and 6.3% year-to-date. Over 1 year the stock is up 31.1% and over 3 years 80.7% (five-year return about 80.4%). The stock carries a valuation score 0/6, signaling few checks for undervaluation. A Discounted Cash Flow (DCF) model yields an intrinsic value of $48.12 per share; at current levels, the stock would be about 30.4% overvalued. Trailing twelve-month Free Cash Flow (FCF) runs around $668.3 million, with forward estimates to $1,166.3 million by 2035 using a two-stage FCF-to-equity approach. The setup invites caution on whether the rally aligns with fundamentals amid interest in recurring revenue.

AWK valuation flags overvaluation as price strength persists, Simply Wall St analysis

January 17, 2026, 8:35 PM EST. AWK traded at US$133.34, up 4.2% in the last week and up 2.3% year-to-date, with a 7.9% gain over the past year; 3-year and 5-year returns show declines of 6.0% and 8.6%. Simply Wall St. assigns AWK 0/6 on undervaluation. The Dividend Discount Model yields about US$105.75 per share, suggesting the stock is roughly 26% above the dividend-based value, i.e., overvalued. The model uses a dividend per share of US$3.91, ROE of 10.42%, payout 56.23%, with expected dividend growth of 3.26% vs 4.56% underlying. A DCF and P/E frame are noted but do not justify a premium at current levels. The takeaway: investors should weigh the premium against dividend sustainability and regulated-utility risk.

Four stock-market predictions for 2026: Gemini, AI shifts, and a potential correction

January 17, 2026, 8:34 PM EST. Forecasts for 2026 hinge on how fast AI spending reshapes markets. The author's four market ideas emphasize a likely power shift in chatbots, led by Gemini and Google's AI ambitions over the earlier dominance of OpenAI's ChatGPT. Analytics show Gemini gaining share and prompting a reassessment of who leads AI platforms, with implications for funding and valuation. The piece warns that betting too boldly on any single name is risky, echoing Morgan Housel's caution that surprises are inevitable. A second outcome foresees a market correction or even a crash if AI enthusiasm cools and sentiment turns risk-off. The pace of disclosure and the potential for new entrants could keep the narrative volatile, with investors seeking durable, long-term opportunities amid uncertainty.

Universal (UVV) valuation diverges: DCF vs. narrative fair value clash

January 17, 2026, 8:23 PM EST.Universal (UVV) trades near $54.32 after muted near-term moves. Latest results show revenue of $2.99 billion and net income of $111.64 million; 1-year TSR 13.05% and 5-year TSR 50.65%. Simply Wall St's narrative fair value sits at $78, implying upside if earnings improve and per-unit costs fall on streamlined operations. By contrast, its DCF model yields a fair value of $251.55, suggesting the market may be underestimating long-term cash flow. The story hinges on cost reductions, digital supply chain, and higher volumes sustaining EBITDA expansion. Risks include tobacco oversupply and lingering tariff/cost headwinds in the Ingredients segment. The analysis flags two rewards and one warning sign. Investors can test assumptions with Do it your way and broaden their watchlists for related ideas.

Flight Centre Travel Group stock advances 29% in 3 months; ROE signals cautious support

January 17, 2026, 8:22 PM EST. Flight Centre Travel Group's stock has risen about 29% in three months. The ROE stands at 8.8%, derived from AU$108m in net profit against AU$1.2b in shareholders' equity for the 12 months to June 2025. The company has delivered 70% five-year net income growth, modestly above the 46% five-year industry growth over the same span, though the ROE is roughly in line with the industry average of 8.8%. Strong earnings retention or effective management may be supporting the trend. With valuation hinging on whether future earnings growth is already priced in, investors will weigh if more upside lies beyond the current momentum.

Albemarle stock price vs intrinsic value: DCF signals undervaluation after 71% one-year gain

January 17, 2026, 8:21 PM EST. Albemarle closed at US$163.04, marking a 71% gain over the last year. The stock's longer-term moves contrast with a mixed valuation picture: a 2 out of 6 score on a six-criterion valuation checklist. A Discounted Cash Flow (DCF) model puts the stock far from today's price, estimating an intrinsic value near US$481.79 per share and implying about a 66.2% discount to that level. By contrast, the article notes that cash flow turned negative in the latest twelve months, tempering the model's optimism. It also starts to outline a P/S-based view, noting earnings volatility. Taken together, the signals suggest undervalued according to the DCF, but investors should weigh other metrics and trend signals before pricing in future growth.

Cleveland-Cliffs Appears Undervalued After Price Rebound, DCF Indicates Fair Value Above $21

January 17, 2026, 8:20 PM EST. Stock in Cleveland-Cliffs is trading near $14.00, after a 9.7% gain in the last week. The shares are up about 36% over 12 months but remain pressured over multi-year horizons, with a 3-year decline of 33.2% and a 5-year drop of 14.6%. A two-stage DCF model yields a fair value of about $21.76 per share, implying roughly 36% upside from current levels. Trailing twelve months free cash flow (FCF) is a loss of about $1.53 billion; projections show FCF turning positive to $372.7 million in 2026 and $577.5 million in 2027, with a long-run path to roughly $1.54 billion by 2035 per the model used. A price-to-sales cross-check is also cited. Sentiment remains tied to the U.S. steel/iron ore market.

Telefónica fair value €4.51 vs €3.34 close implies a 26% valuation gap

January 17, 2026, 8:06 PM EST. Telefónica (BME:TEF) shares fell 1.18% in the latest session and are down 25.8% over three months, with the price at €3.34. The pullback suggests fading short-term momentum, even as a 5-year total shareholder return of 25.36% hints at a longer-run trend. Simply Wall St's fair-value work puts €4.51 as intrinsic value (intrinsic value models estimate what a stock is truly worth) and analyst targets back a discount to the current price, creating a roughly 26% gap. The company is monetizing non-core assets (Argentina, Peru, Colombia, Uruguay, Ecuador) to reduce geographic risk and free more than €3 billion. A focus on core markets-Spain, Brazil, Germany, the UK-could lift free cash flow and ROCE (return on capital employed). Risks include high debt and competitive pricing pressure. Full narrative available.

FirstService (TSX: FSV) valuation flags upside despite mixed returns

January 17, 2026, 8:05 PM EST.FirstService, the Canadian property services group, trades at CA$225.55. In the short term, it rose 6.37% in 30 days but fell 12.13% in 90 days, with a 1-year TSR (total shareholder return) down 13.89%. Over 3 and 5 years, TSR (total shareholder return) gains 24.57% and 34.08%, signaling a stronger longer-term picture. Revenue runs around CA$5.48 billion with net income of CA$138.55 million. A narrative sets fair value at CA$264.61, implying the stock is undervalued. Acquisitions in Fire Protection and Roofing expand reach and operating leverage. Yet risks include softer organic growth and weather-driven volatility. The current P/E is 53.5x, above industry 7.6x and peer 47.2x, underscoring valuation risk if sentiment cools. A breakdown explains the assumptions and a discount rate just under 9%.

Domino's Pizza: DCF Signals Value Gap as DPZ Trades Near $400

January 17, 2026, 8:04 PM EST. Domino's Pizza (DPZ) trades around $400 a share after a week of declines. The piece frames how the price lines up with expectations for this established DPZ name that attracts long-time holders and new investors. Simply Wall St's valuation check gives DPZ 2/6. In a Discounted Cash Flow view, the latest twelve-month Free Cash Flow is about $622.3 million, with 2028 projected at $787.4 million and a longer path implying an estimated intrinsic value around $347.11 per share – roughly 15.3% overvalued versus the current price. The article also notes a Price-to-Earnings (P/E) cross-check, but it finishes before delivering a final conclusion.

SS&C Technologies Seen Undervalued by DCF After Steady Trade Near $85

January 17, 2026, 7:53 PM EST.SS&C Technologies Holdings trades near $85.78, with a 1.4% weekly decline and 1.1% over 30 days. It rose 10.6% in the last year and 59% over three years as investors weigh its role for financial institutions. Simply Wall St gives a valuation score of 4/6. The model's DCF result shows a latest twelve-month FCF of about $1.31 billion and an intrinsic value of roughly $156.77 per share, implying the stock is undervalued by about 45.3% at current levels. The analysis underlines its fit for fintech and outsourcing themes. A price-to-earnings approach is mentioned but the excerpt provides limited detail.

Airship AI Holdings jumps as P/S premium persists despite losses

January 17, 2026, 7:52 PM EST. Airship AI Holdings (AISP) jumped 15.74% in Friday trading as investor interest in AI-focused surveillance software picked up. The move aligns with a momentum streak: 7-day return 39.35% and 30-day gain 52.65%. But longer-term performance remains weak: 1-year total shareholder return down 14.79% and 3-year down 57.35%. The stock trades at $4.32, versus an analyst target of $8.00. On a P/S basis, it trades at 12.3x, a premium to the fair 6.5x and well above the US software industry average of 4.7x and peers at 4.3x. A recent net income loss of $43.82 million underscores earnings pressure. With sentiment or growth expectations needing to improve for the multiple to narrow, investors should test scenarios using screeners or your own model.

TOTO (5332) valuation check after momentum; DCF fair value gap vs. price

January 17, 2026, 7:51 PM EST. TOTO's stock trades at ¥4,724 after an 11.60% 30-day gain, with a 7.71% year-to-date rise. By contrast, the five-year total shareholder return remains negative, down about 12.5%. The near-term momentum has investors revisiting a plumbing fixtures business seen as recovering in sentiment. On a P/S basis, TOTO sits at 1.1x, above the peer average (1x) and industry (0.6x), yet below a calculated fair value around 1.6x. A DCF model, meanwhile, points to a fair value of roughly ¥3,460.5, implying the current price is above what the model deems fair value if expectations hold. Risks include a recent large one-off loss and a low return on equity, potentially capping upside.

Klarna Group valuations show overvaluation as BNPL scrutiny weighs on shares

January 17, 2026, 7:50 PM EST. Klarna Group's shares closed at US$29.00, with a 7-day decline of 7.8%, a 30-day decline of 1.5%, and a year-to-date gain of 1.5%, as investors weigh risk and return amid BNPL scrutiny. Regulators and merchants have sharpened questions about the business model, helping explain a recent reassessment of value. The company scores 2 out of 6 on our valuation checks. In Excess Returns, the model starts with a book value of US$6.49 and a stable EPS of US$1.06, yielding an excess of US$0.33 and an intrinsic value of about US$15.26 per share, implying the stock is roughly 90% overvalued. The price/sales multiple is 3.41x, adding to caution.

Optimistic Investors Push Allied Architects, Inc. (TSE:6081) Shares Up 46% But Growth Is Lacking

January 17, 2026, 7:49 PM EST. Allied Architects, Inc. (TSE:6081) jumped 46% in the last month, with a 95% gain over 12 months. Price-to-sales ratio (P/S), a rough measure of revenue expectations, sits at 1.3x versus a Japan Media industry median near 0.9x. Revenue declined 13% in the past year, and over three years the company has shrunk sales 38%. Investors appear to be pricing in a near-term turnaround, even as the broader industry is forecast to grow about 6.6% next year. No current analyst forecasts are provided. With the P/S near peers despite weak growth, the stock carries the risk that multiples could compress if revenue momentum fails to improve. The case hinges on whether a forthcoming pickup in sales materializes for Allied Architects.

Maggie Beer Holdings insiders buy AU$2.8 million; 41% stake signals alignment

January 17, 2026, 7:33 PM EST. Maggie Beer Holdings Ltd (ASX: MBH) (listed on the Australian Securities Exchange) saw insiders (company executives and large holders) lift their stake over the last 12 months, including Angelo Kotses buying AU$2.8 million of shares at about AU$0.065. The stock traded near AU$0.093 at the time, so the purchase was at a lower price. Insider buying is a datapoint investors watch but does not guarantee returns. Insiders own about 41% of the company, worth roughly AU$17 million, suggesting alignment with other shareholders. There were no insider sales in the past year. The report also notes three warning signs in the company's risk profile and cautions investors to weigh this alongside fundamentals.

Could $1,000 in a Trump Account grow over 18 years?

January 17, 2026, 7:18 PM EST. Under the One Big Beautiful Bill Act, a Trump Account would offer a pilot program that deposits $1,000 for eligible children born 2025-2028. The plan emphasizes long-term investing in mutual funds or ETFs (exchange-traded funds), with the SPDR S&P 500 ETF (SPY) used as a proxy for the broad S&P 500. Assuming the historic 10% annual return, the balance would grow from $1,000 to about $5,560 by year 18 (roughly a $4,560 gain). If kept invested into adulthood, projections rise to roughly $10,835 by year 25 and $490,371 by year 65, illustrating the power of compounding. Note that returns are not guaranteed and inflation is not factored into these estimates.

FFI Holdings near fair value as DCF and Gordon Growth suggest AU$5.1 per share

January 17, 2026, 7:17 PM EST. FFI Holdings' estimated fair value per share sits around AU$5.1 to AU$5.14, using a Dividend Discount Model (Gordon Growth). The current price near AU$4.55-AU$4.6 suggests it trades close to fair value, while peers trade at a ~31% premium. The analysis notes a DCF approach with DPS-based valuation, using a perpetual growth rate tied to a 5-year average of the 10-year bond yield at 3.3% and a cost of equity of 6.7%. Per-share value = AU$0.20 / (0.067 − 0.033) ≈ AU$5.1. Inputs matter; results depend on the discount rate and expected cash flows. The method omits industry cyclicality and future capital needs. Readers are advised to recompute with their own inputs.

Telix TLX valuation after first U.S. BiPASS Phase 3 patient dosed

January 17, 2026, 7:02 PM EST. Telix Pharmaceuticals trades at A$11.48 after dosing the first U.S. patient in BiPASS Phase 3, spotlighting Illuccix and Gozellix in prostate cancer imaging. The update comes as the stock shows a 1-day gain of 2.96% and a 7-day gain of 2.14%. The rally has cooled, but the longer-term thesis remains intact. At a P/S of 3.9x, the company trades well below Australian biotech peers and a fair level near 7x, suggesting revenue is priced conservatively. A rough fair value via a DCF (discounted cash flow) model puts Telix near A$28.99 per share, implying roughly a 60% discount to today's price. The implied intrinsic value (the stock's true worth from fundamentals) could rise if earnings visibility improves. Risks include BiPASS results and slower Illuccix rollout. Illuccix and Gozellix potential keeps the narrative alive, but near-term clarity is needed.

Rathbones: Analysts split on fair value drift versus sector peers

January 17, 2026, 6:49 PM EST. Rathbones Group's fair value estimate lifted to £21.30 from £21.11 as analysts slightly tweak inputs, with a marginally higher discount rate and a smaller projected revenue decline. In a sector-wide backdrop, some peers offer more upside while Rathbones still aims to narrow the gap to its central valuation. Deutsche Bank raises its target by £1, signaling a more bullish view, though risks persist around costs, transparency and momentum. Jefferies launches coverage with an Underperform rating and a £16.50 target, indicating greener opportunities elsewhere in wealth management and implying nearer-term value constraints. The mix of optimism and caution underscores a divergent narrative among analysts. Track updates via a watchlist, portfolio, and the Simply Wall St Community for fresh perspectives. Brief glossary: Fair Value equals intrinsic value; discount rate converts future cash into today's terms.

Western Uranium grants stock options to align incentives; CEO buys shares

January 17, 2026, 6:48 PM EST. Western Uranium & Vanadium said its president and CEO, George Glasier, bought 100,000 common shares on December 29-30, 2025 at CA$0.48, lifting his direct stake from 4,928,516 to 5,028,516 shares and from about 6.9% to 7.0% of outstanding shares. The stake stays under 10% due to prior dilution, triggering an early warning filing. On Jan 15, 2026, the company granted 1,350,000 stock options to officers, directors and employees at CA$0.90, vesting in three tranches through Jan 31, 2027; the move aligns management incentives with shareholder value amid development and permitting work for uranium and vanadium projects. Analyst rating on TSE:WUC is a Hold with CA$0.81 target. Spark's Analyst rates it Neutral, citing weak profitability and negative cash flow, but a debt-free balance sheet and mixed technicals. Western Uranium is a Colorado-Utah uranium-vanadium developer with Mustang and Sunday Mine Complex.

Harvey Norman Holdings: ROE Near Industry, Earnings Slump Clouds Outlook (ASX: HVN)

January 17, 2026, 6:47 PM EST. Harvey Norman Holdings (ASX: HVN) has fallen 7.1% over three months as investors assess its fundamentals. The piece centers on ROE (return on equity), which stands at about 11% for the trailing twelve months to June 2025, with AU$526 million in net profit against AU$4.8 billion of shareholders' equity. While this sits near the industry average of ~10%, the five-year net income has declined 13%, suggesting a profitability/earnings decline challenge. By contrast, the industry posted about 6.3% earnings growth over the same period, widening the contrast and raising concerns about HVN's growth path. The company's payout ratio is 64% (retaining 36%), which tempers reinvestment. The report notes whether the market has priced in the future outlook, pointing to an intrinsic value infographic as part of the analysis.

Insider Buying Offsets 11% Selloff for Carbonxt Group (ASX:CG1)

January 17, 2026, 6:46 PM EST. Insiders bought AU$2.03 million of Carbonxt Group Limited (ASX:CG1) shares over the past 12 months, a stake now valued at AU$2.66 million after an 11% drop. While insider buying isn't a guarantee of performance, it signals alignment with shareholders. The largest purchase was Simon Maher's AU$1.2 million buy at AU$0.06 per share, well below the recent AU$0.086 level, so it offers limited read-through about current sentiment. There were no insider sales in the period. Insider ownership stands at about 24% of the stock, worth roughly AU$8.9 million. No transactions occurred in the last three months. Analysts at Simply Wall St flag two warnings for investors to weigh before trading, underscoring remaining risks.

History hints the S&P 500 could climb again in 2026

January 17, 2026, 6:30 PM EST. History offers a clear answer for 2026: the S&P 500 could keep rising, though risks loom. The index has climbed double digits for three straight years, up about 78% in that span, powered by AI growth stocks and a supportive, lower-rate environment that boosts corporate earnings and consumer spending. The market now trades near levels last seen in the dot-com era, as measured by the inflation-adjusted Shiller CAPE ratio, signaling valuation scrutiny ahead. Demand for AI products remains robust, with data-center firms expanding capacity and firms like Alphabet and Meta reporting steady earnings growth. If the AI cycle stays intact, the market may push higher again. But higher valuations, a potential shift in rates or policy and past tariffs headwinds could temper upside.

Teck Resources TECK.A:CA Long-Term Buy near 62.38, Stop at 62.07

January 17, 2026, 6:16 PM EST. TECK.A:CA, Teck Resources Ltd Class A, is covered for a long-term view with data dated Jan 17, 2026. Traders are advised to buy near 62.38, with a stop at 62.07 and no short plans at this time. The signals are AI-generated by Stock Traders Daily, with the timestamp noted. Ratings show Near-term: Strong, Mid-term: Weak, and Long-term: Weak. The plan provides no defined price target beyond the entry; risk control rests on the 62.07 stop. Readers should treat AI guidance as provisional and subject to market change.

Applied Digital elevates co-founder Jason Zhang to President

January 17, 2026, 6:15 PM EST. Applied Digital Corporation said on January 14, 2026 its board approved promoting co-founder and Chief Strategy Officer Jason Zhang to President and Co-Founder. The move formalizes his role in guiding strategy and growth as the company scales its AI infrastructure platform. Zhang, a former investor at Sequoia Capital and MSD Capital, has led leases for the Polaris Forge 1 and Polaris Forge 2 data center campuses in North Dakota and will continue to work with Wes Cummins, who remains chairman and CEO. The employment agreement was amended to set Zhang's annual base salary at $700,000. Analysts cited by Spark on APLD called the stock a Buy with a $41 price target, though Spark notes weak financial quality and elevated leverage. APLD designs and operates hyperscale data centers with a focus on AI and cloud workloads.

Abundant US nat-gas supplies pressuring prices

January 17, 2026, 6:01 PM EST. Feb Nymex natural gas (NGG26) settled down 0.8%, keeping pressure on prices after a three-month low. Abundant US supplies weigh on the market as the EIA reported inventories about 3.4% above the five-year seasonal average. Forecasters see colder-than-normal US temperatures for much of the January 21-30 period, which could lift heating demand. Pressure from weak LNG export feedgas at Corpus Christi and Freeport allows storage to build, a bearish factor. The EIA on Tuesday trimmed its 2026 dry gas production forecast to 107.4 bcf/d. On Friday, Lower-48 gas production was about 113.0 bcf/d, while demand ran around 104.9 bcf/d, per BNEF, and LNG net flows stood at about 19.8 bcf/d. Rigs declined to 122 in the week.

Lottery Corporation TLC: Individuals Own 51%, Institutions 48%; Top 25 Hold 46%

January 17, 2026, 6:00 PM EST. ASX-listed The Lottery Corporation Ltd (ASX:TLC) shows a broadly dispersed shareholder base. Individual investors own 51% and institutions (institutional investors such as pension funds and asset managers) hold 48%-a split that keeps significant retail sway alongside established funds. The top 25 shareholders control about 46% of the stock, indicating no single owner dominates. The largest single holder is AustralianSuper Pty Ltd with about 14% of shares. The spread suggests both public participation and institutional backing, with the caveat that large holders could move the price if they trade heavily. Insider ownership data aren't provided here. Analysts cover TLC and forecast growth, but the ownership mix is a separate lens on potential influence over corporate decisions.

Cencora expands credit facilities to back OneOncology deal

January 17, 2026, 5:49 PM EST. Cencora, Inc. expanded its liquidity toolkit to back the OneOncology acquisition. On January 12, 2026, the company amended its existing revolving credit agreement, boosting total commitments by $1.0 billion to $5.5 billion. It also secured a new senior unsecured multi-year term loan facility totaling $1.5 billion in two tranches and a separate $3.0 billion 364-day term loan, primarily to finance the acquisition, refinance OneOncology's debt, and cover fees. The facilities replace the previously arranged $4.5 billion bridge facility, signaling strong banker support with JPMorgan Chase, Citibank, Bank of America, Wells Fargo, BNP Paribas, Société Générale, and MUFG in lending, advisory, or securitization roles. Analysts have mixed views: a Buy at a $415 target for COR, and Spark rates the stock Neutral.

Amer Sports valuation: DCF signals overvaluation despite high P/E

January 17, 2026, 5:47 PM EST. Amer Sports (AS) traded at $37.03, down 3.9% in the past week. The stock has fallen 2.3% over 30 days and 1.3% year-to-date, while the 1-year return stands at 24.4%. Simply Wall St gives a valuation score of 1/6. The report uses a two-stage Free Cash Flow to Equity (FCF) model – cash available to equity holders after capital needs – with trailing FCF about $254.1 million; projections rise to $1,448.9 million by 2035, and interim years of $472.2 million (2026) and $655.0 million (2027). Discounting yields an intrinsic value of about $32.22 per share, implying the stock is roughly 14.9% overvalued at $37.03. The stock also trades at a P/E of 65.97x, signaling high earnings expectations baked into the price.

Axalta Coating Systems valuation after price move; fair value suggests upside

January 17, 2026, 5:46 PM EST.Axalta Coating Systems (AXTA) trades around US$33.57 after a period of mixed momentum. Over 90 days the stock rose about 17.95%, but the one-year total return shows a -7.47% decline, signaling a cooled initial optimism. A recent analysis puts a fair value of about US$36.87, implying an intrinsic discount near 49% and potential upside if earnings, margins and capital allocation improve. The thesis cites rising demand for advanced and sustainable coatings amid EV adoption, stricter VOC regulations, and product innovations such as NexJet. Risks include possible volume softness in core coatings and cost/synergy execution. Investors are reminded to weigh valuation against the forecast and to consider how a future earnings multiple may differ from today.

Sky Metals insiders rewarded as shares jump 32%, AU$29 million market cap rise

January 17, 2026, 5:45 PM EST. Sky Metals Limited (ASX: SKY) shares rose 32% last week, lifting market capitalization by about AU$29 million. Insiders who bought stock over the past year saw a strong gain: a three-person purchase totaling AU$578k is now worth AU$1.29 million, a ~123% gain on the initial stake. Executive Chairman Norman Seckold led the year-long buying with AU$520k of shares at around AU$0.065, well below the latest price of AU$0.14. The move suggests insider confidence, though it does not by itself indicate a valuation view. In the last 12 months, insiders bought but did not sell. Insider ownership sits near 17% (about AU$20 million). Sky Metals still reports losses, which keeps risk in focus, even as alignment with insiders could support a re-rating if losses narrow.

Three Vanguard ETFs to Weather a 2026 Recession

January 17, 2026, 5:33 PM EST. The article argues a recession could loom in 2026 even as benchmarks push higher. An MDRT December 2025 survey found about 80% of Americans worry about a downturn. It urges investors to stay invested and use ETFs to temper risk. The piece centers on three Vanguard funds. First, the Vanguard S&P 500 ETF (VOO) tracks the S&P 500, about 500 large-cap stocks, with a long record of weathering recessions. Capital Group data show the index has produced positive total returns in every 10-year stretch over the last 82 years. Holding VOO for a decade can damp volatility. The second is the Vanguard Total Stock Market ETF (VTI), spanning the entire US equity market with thousands of stocks for broad diversification. A third Vanguard fund rounds out the lineup.

Analysts lift Catalyst Metals forecast; 2026 revenue and EPS rise, price target raised

January 17, 2026, 5:32 PM EST. Analysts have upgraded near-term forecasts for Catalyst Metals (ASX:CYL), lifting revenue and EPS projections for 2026. The four-analyst consensus now sees AU$622 million in revenue for 2026, up 72% from the prior year, and AU$0.83 in statutory EPS, up 134%. The upgrade also lifts the price target to AU$12.16, about 16% higher than before. The stock has risen about 24% in the past week to AU$9.00. The revisions imply faster growth than the broader mining sector, which is expected to grow about 7.7% annually. Caution remains: earnings quality concerns are noted alongside the optimistic outlook.

Pro Medicus (ASX: PME) slides 3.5% this week as five-year returns track earnings growth

January 17, 2026, 5:31 PM EST. Pro Medicus Limited (ASX: PME) shares slid 3.5% this week as investors weigh long-term fundamentals against a steep run in the past five years. The stock is about 401% higher than five years ago, and total shareholder return over the period topped 410% on the back of dividends. Over five years, EPS grew about 38% annually, roughly matching the 38% annual rise in the share price, suggesting sentiment tracks fundamentals. Insider buying gained traction in the last three months. The broader market rose about 11% last year, but PME fell roughly 18% including dividends. For patient investors, the recent sell-off may present a potential entry point.

BCE looks undervalued after mixed returns; fair value CA$36.47 vs CA$33.59

January 17, 2026, 5:30 PM EST. BCE (TSX:BCE) trades at CA$33.59 amid a mixed return profile. A 1-month gain of 5.23% sits beside a 3-year TSR decline of 32.44%. A discounted cash flow framework yields a fair value of CA$36.47, signaling the stock is undervalued versus the current price. Analysts' targets span from CA$30.00 to CA$45.00, with a consensus CA$35.41. The narrative assumes revenue growth in the low single digits, stable margins, and a discount rate of 7.59%. Risks include regulatory limits on fiber buildout and high capital needs that could squeeze free cash flow and margins. The question for investors is whether valuation leaves room for upside or already prices in future growth. BCE revenue: CA$24.486 billion; net income: CA$6.172 billion.

Hawkins (HWKN) overvalued after multi-year rally, DCF fair value trails price

January 17, 2026, 5:29 PM EST. Hawkins (HWKN) trades around $152 after a multi-year rally, prompting questions about further upside. The stock's valuation screen gives a 1/6 score, with a DCF-based intrinsic value of about $98.23 per share-roughly 54.7% below the current price, i.e., overvalued on this method. The model uses a two-stage free cash flow to equity, with trailing FCF around $75.1 million and forecasts of $80.7 million in 2026, $97.0 million in 2028, and about $117.2 million by 2035. Short-term moves are mixed, yet the five-year run has been strong, fueling questions about growth prospects and risk. A quick P/E snapshot accompanies the DCF view as investors weigh sentiment against value.

Charles River Laboratories: DCF signals 12.5% undervaluation at $219.70

January 17, 2026, 5:28 PM EST. Charles River Laboratories International trades around $219.70. The stock delivered 34.4% in the last year; 30-day gains 12.1%; YTD 8.5%. Over 3 and 5 years, returns are negative (-9.7% and -21.6%). The company's gains reflect demand for contract research in drug discovery and preclinical work. A valuation review grades the stock 4/6. Using a DCF model with a 2-stage Free Cash Flow to Equity, it starts from about $497.2 million in trailing FCF and projects to $851.1 million in 2035. The resulting intrinsic value is about $251.07 per share. At roughly $219.70, the stock sits about 12.5% below the intrinsic value, implying it is undervalued on this metric.

Cotton futures fall on Friday as export pace trails five-year average

January 17, 2026, 5:18 PM EST.Cotton futures fell Friday, with most contracts down 15 to 30 points. The US dollar index was down about 343 points, while crude oil slid $1.64 a barrel. USDA Export Sales for 2024/25 stood at 4.213 million running bales sold or shipped, about 37% of the USDA projection and roughly 12 percentage points behind the five-year average pace. ICE cotton stocks were unchanged at 15,526 bales. The Cotlook A Index dropped 100 points to 78.45 cents per pound. The USDA Average World Price (AWP) for next week rose to 55.35 cents/lb, up 11 points. Quotes: Dec 24 at 67 (-15); Mar 25 at 68.49 (-23); May 25 at 69.76 (-28). On the date of publication, Alan Brugler had no positions.

Soybeans drift higher on Friday ahead of MLK Day holiday

January 17, 2026, 5:16 PM EST. Soybeans edged higher on Friday, reversing early weakness as the market digests export pace. The national average cash price rose to $9.85 1/2, while soymeal futures fell about 70 cents and soy oil slipped 20-25 points. Markets will be closed Monday for the Martin Luther King Jr. Day holiday. Export Sales show total soybean commitments at 30.637 MMT as of 1/8, about 25% below a year earlier and 71% of the USDA projection, with shipments at 17.984 MMT or 42% of the USDA estimate and well under the 60% average pace. Brazilian crops gained on the day after Safras boosted its projection by 0.52 MMT to 179.28 MMT. Front-months: Mar 26 at $10.55 1/4, nearby cash $9.85 1/2, May 26 $10.67, Jul 26 $10.79 1/4.

Soybeans rise on Friday as futures rebound; export pace and COT trim long

January 17, 2026, 5:15 PM EST. Friday soybeans posted 4-5 cent gains across most contracts, while March futures slipped 4.75 cents on the week. The cmdtyView Cash Bean price rose 5.25 cents to $9.87 1/4 per bushel. Soymeal futures gained 80 cents to a higher level, despite March posting a weekly drop of $13.70. Soy Oil futures fell 18 to 36 points, though the weekly move stayed up 292 points. Markets will be closed Monday for the Martin Luther King Jr. Day holiday and reopen Monday evening. The Commitment of Traders (COT) report shows speculators trimming net longs by 44,756 contracts to 12,961 as of 1/13. Export sales data show total commitments at 30.637 MMT as of 1/8, 25% below year-ago, 71% of USDA projection; shipments at 17.984 MMT, 42% of USDA estimate and below normal pace.

Lucid stock at $10 after reverse split amid tightening cash runway

January 17, 2026, 5:14 PM EST.Lucid Group trades around $10 as its cash runway tightens and scale remains elusive. The company stays in start-up mode, building manufacturing and sales infrastructure to compete with incumbents. In Q3 2025 it warned cash would fund operations through the first half of 2027. A reverse split in August 2025 lifted the price but did not fix the business; without the split, shares would trade well under $1. The stock has fallen about 49% since the split. Investors worry about losses, capital needs and the risk of delisting if funding stalls. All told, the article cautions that only the most aggressive investors should consider Lucid below about $11.

Vital Farms stock (VITL) mixed price action keeps undervaluation case intact

January 17, 2026, 5:13 PM EST. Vital Farms trades near US$29.49, with mixed price action: -1.9% in 7 days, -8.4% in 30 days, -1.1% YTD, but up 74.9% over 3 years and 19.3% over 5 years. Simply Wall St's valuation checklist scores 4/6 on valuation. A two-stage DCF model, which projects future cash flows and discounts them to today, yields intrinsic value around US$305.16 per share, implying roughly a 90% undervalued gap versus the current price. The model uses 12-month free cash flow around US$6.7 million, with projections to 2027 of US$103.17 million and to 2035 of US$781.09 million. The P/E ratio, or price-to-earnings (how many dollars investors pay per dollar of earnings), adds another lens, though normal levels vary with growth expectations.

Himax Technologies (HIMX) overvalued after rally; DCF fair value around $1.87 vs $8.59 price

January 17, 2026, 5:12 PM EST. Himax Technologies (HIMX) remains at $8.59, up 5.1% in the last week and 6.8% over 30 days. YTD is flat; 1-year return barely positive; 3- and 5-year gains in the low- to mid-30% range. The Simply Wall St review flags a mixed valuation, scoring 3 of 6. A two-stage Discounted Cash Flow (DCF) approach-valuing a company by discounting expected future cash flows-yields an intrinsic value of about $1.87 per share. With the current price more than four times that, the model flags the stock as overvalued-about 359% above fair value. In short, the price reflects optimism around Himax's role in semiconductors and display-driver tech, but the cash-flow-driven valuation suggests investors are paying a steep premium.

Banner (BANR) earnings view hinges on net interest margin as NPAs rise

January 17, 2026, 5:10 PM EST. Banner Corporation is seen posting a quarterly EPS of $1.46, about 10% higher year over year, with revenue near $170.27 million. Analysts expect improvements in net interest margin (NIM) – a bank's lending profitability – and the efficiency ratio, even as non-performing assets rise. The near-term narrative hinges on converting Banner's West Coast franchise into steadier earnings, with higher EPS and revenue helping, though rising CRE and construction exposure keep credit quality in focus. Banner's 2024-25 results showed higher net interest income and wider margins; the 2028 outlook calls for about $815.0 million in revenue and $228.9 million in earnings. Two fair-value estimates span $47.34-$73.40 per share, with roughly 13% upside; NPAs and CRE risk cap upside potential.

Cattle futures slide into long weekend; cash steady, feeders retreat

January 17, 2026, 5:09 PM EST. Live cattle futures closed Friday lower, with contracts down $3.90 to $4.50. The week saw February down $1.57. Cash trade centered around $233 per cwt in the South and $232-$235 in the North. Feeder cattle retreated, giving back most of the week's strength; the Friday session saw losses of $6.50 to $8.10. The CME Feeder Cattle Index rose 73 cents to $370.15 on Jan. 15. The market will be closed Monday for Martin Luther King Jr. Day. USDA APHIS reported several new New World Screwworm cases in Mexico, bringing active Tamaulipas cases to eight. CFTC data showed managed money added 6,555 contracts to net long in live cattle futures and options to 101,316 as of Jan. 13; feeder specs trimmed net long by 530 to 16,308. Weekly slaughter was estimated at 562,000 head, above last week but below last year.

Coffee futures slide as Brazil rain forecast weighs on arabica, robusta

January 17, 2026, 5:08 PM EST. March arabica (KCH26) settled down 0.78%, with March ICE robusta (RMH26) off 0.07%. Prices gave up an early advance as updated weather forecasts raised rain chances in Brazil's coffee belts next week. Minas Gerais, the largest area for arabica, received 26.5 mm of rain in the week ended Jan 9, about 29% of the historical average, according to Somar Meteorologia. ICE arabica inventories sat at a 1.75-year low of 398,645 bags on Nov 20, later rebounding to a 2.5-month high; robusta stocks rose from a 1-year low to 4,278 lots. Brazil's 2025 production is seen at 56.54 million bags (up 2.4%); Vietnam's 2025/26 output is projected higher, with exports rising sharply. The sector faces ample supplies, per ICO and FAS outlooks, with ending stocks dipping about 5.4% to 20.148 million bags.

Fund Short Covering Lifts Sugar Prices

January 17, 2026, 5:07 PM EST. March NY world sugar #11 rose 2.54% to trade higher, while March London ICE white sugar #5 gained 2.37%, as fund short covering ahead of a three-day weekend in the U.S. for Martin Luther King Jr. Day. The advance follows Thursday's declines to one-month and two-month lows. India's production data showed 2025/26 output up 21% y/y to 15.9 MMT through Jan. 15; Brazil's Center-South output through mid-Dec rose 0.9% to 40.158 MMT. Covrig Analytics lifted its 2025/26 global surplus estimate to 4.7 MMT, while projecting 1.4 MMT for 2026/27. ISMA raised India's 2025/26 production to 31 MMT, signaling potential higher exports; ISO maintains a 2025/26 global surplus amid broader supply.

Iran Tensions Support Crude Prices as US Expands Middle East Presence

January 17, 2026, 5:06 PM EST. Oil rose Friday as tensions in Iran supported crude prices despite a firmer dollar. February WTI (CLG26) settled up 0.25% and February RBOB (RBG26) up 0.08%. Geopolitical risk around Iran helped cap Thursday's selloff. The United States moved a carrier group into the Middle East, though prospects for an immediate strike appeared diminished. Short covering also lent support. With Iran, OPEC's fourth-largest producer (around 3 million bpd), disruption remains a risk if protests widen. Traders tracked tanker disruptions near the Caspian Pipeline Consortium and resilient China demand. OPEC+ signaled a pause on Q1-2026 hikes, while the IEA sees a global oil surplus of roughly 4.0 million bpd in 2026.

Dollar recovers on Trump Fed Chair speculation as data weighs rate-cut odds

January 17, 2026, 5:05 PM EST. The DXY rose 0.04% on Friday as markets priced in a potential Fed chair shift after President Trump signaled a decision soon. Hassett's perceived dovishness vs a hawkish alternative like Warsh kept the debate alive and could support the dollar if a hawk takes the helm. U.S. data offered mixed signals: Dec manufacturing production rose 0.2% and was revised higher to +0.3% for Nov, while the Jan NAHB housing market index fell to 37. The market is pricing about a 5% chance of a -25 bp rate cut at the FOMC meeting on Jan 27-28; a larger cut remains in view for 2026. The ECB stance, the BOJ policy path, and risk events kept the yen bid and USD/JPY down roughly 0.35%.

Cotton futures slide; December leads retreat as outside markets mix

January 17, 2026, 5:04 PM EST. Cotton futures posted declines across most contracts, with the December contract down 80 points on Friday. The move came as the dollar index fell and crude oil rose, providing some outside support in other sectors. Speculators trimmed risk, with CFTC data showing non-commercial net shorts shrinking by 12,969 contracts to 17,549. The Seam reported 868 online cash bale sales at 67.83 cents per pound. ICE cotton stocks were unchanged, leaving 265 bales certified. The Cotlook A Index slipped 90 points to 84.90 cents per pound. The USDA Adjusted World Price was raised 223 points to 61.06 cents per pound. Nearby contracts settled lower: Dec 24 at 72.72 cents, down 30; Mar 25 at 74.52, down 25; May 25 at 75.61, down 26.

Commerzbank valuation under scrutiny as DCF signals €67.97 fair value vs €34.95 price

January 17, 2026, 5:03 PM EST. Commerzbank shares hover around €34.95 as investors compare momentum with fundamentals. The bank reports €11,320 in revenue and €2,427 in net income, with a value score of 3. The 90-day price gain of 17.84% contrasts with a year-to-date decline of 3.98%, though the five-year TSR remains solid. Market implied near-term fair value sits at about €33.87, below the current price, while a DCF model on Simply Wall St delivers a fair value of €67.97, implying roughly a 48.6% gap. Ongoing restructuring, cost discipline, and digital transformation aim to push the cost/income ratio toward 50% by 2028, lifting margins if successful. Risks include possible delays in digital initiatives and higher regulatory costs. Investors face a valuation tug between value and growth narratives.

Arm Holdings Poised as a Top Growth Stock in 2026 Tech Rally

January 17, 2026, 5:02 PM EST. Arm Holdings has drawn renewed investor attention as tech shares ride a nascent rally in early 2026. The stock pulled back after a late-2025 surge, trading around $105.78 and down about 40% from its 52-week high. Arm Holdings designs and licenses processor architectures; it does not manufacture chips, earning revenue from licenses and royalties tied to its IP. Its technology powers smartphones, cars, data centers and other devices, and almost all smartphone processors rely on its architecture. Bulls argue AI semiconductor demand could sustain growth even as valuation remains a concern. The backdrop includes stronger AI infrastructure spending and double-digit capex growth by hyperscalers in 2026. A sustained AI cycle could lift Arm Holdings, but a softer tailwind caps upside.

Lean hog futures steady at midday as MLK holiday looms; CME index up 11 cents

January 17, 2026, 5:01 PM EST. Lean hog futures were nearly steady at midday, with nearby contracts within a dime of unchanged. The CME Lean Hog Index rose 11 cents on Jan. 13 to $80.50. Markets will be closed Monday for the Martin Luther King Jr. Day holiday. The USDA's national base hog price was not reported Friday morning due to light volume. The pork carcass cutout value advanced a dime to $93.70 per cwt, led by gains in the loin and belly primals. Estimated federally inspected hog slaughter for Thursday was 492,000 head, lifting the weekly tally to 1.973 million – 7,000 higher than last week and about 46,900 above the year-ago week.

Wheat futures rise on Friday as export data, MLK holiday loom

January 17, 2026, 5:00 PM EST. Wheat futures closed higher on Friday as the complex posted gains of 6 to 11 cents. Chicago SRW rose 8-9 cents; KC HRW up 10-11; MPLS spring up 6-7. Markets will be closed Monday for MLK Day and reopen Monday evening. Export data through Jan 8 show commitments at 20.392 MMT, up 15% year over year, or about 83% of USDA's export projection and just below the 85% average pace. Shipments total 15.465 MMT, 63% of USDA estimate and above the 59% average. A South Korean importer bought 92,300 MT of US wheat in Thursday's tender. Prices: CBOT Mar 26 at $5.19 1/4, May 26 at $5.30 1/4; KCBT Mar at $5.28, May at $5.39 1/4; MIAX Mar $5.69, May $5.80 1/2.

Cattle futures slide Friday as cash trade weak ahead of MLK Day

January 17, 2026, 4:59 PM EST.Live cattle futures are down $4.25 to $4.85 Friday. Cash trades in the north were $232-235. The Fed Cattle Exchange showed $232 on 298 of 974 head offered. Feeder cattle futures are lower, down about $7.15-$8.75 at midday, erasing earlier strength. The CME Feeder Cattle Index rose 27 cents to $369.42 on Jan. 13. Markets will be closed Monday for Martin Luther King Jr. Day. The APHIS update shows new cases of New World Screwworm in Mexico, including six in Tamaulipas; active cases up to eight. USDA Wholesale Boxed Beef prices were higher; the Choice-Select spread widened to $1.61. Slaughter week-to-date at 469,000, up 4,000 vs last week, but 15,813 below a year ago. Front-month quotes: Feb 26 Live Cattle 231.800, Apr 26 233.575, Jun 26 229.225; Feeder: Jan 26 361.250, Mar 26 355.900, Apr 26 354.300.

Wheat futures rally into long weekend as export data supports demand

January 17, 2026, 4:56 PM EST. Wheat futures rallied into the long weekend across the three markets. Chicago SRW rose 7-8 cents on Friday, with the March contract up about 0.75 cent. KC HRW front months gained 9-10 cents; March was down 3 cents on the week. MPLS spring wheat added 2-3 cents, March down 2.5 cents. Markets are closed Monday for MLK Day and reopen Monday evening. The CFTC Commitment of Traders shows managed money trimming 936 contracts from its net short in CBT wheat futures and options to 106,229 by Tuesday. As of Jan. 13, specs were net short KC wheat futures and options by 12,781, down 2,874 from the prior week. Export data through Jan. 8 put total wheat commitments at 20.392 MMT, up 15% YoY and 83% of USDA projection; shipments at 15.465 MMT, 63% of USDA estimate. A South Korean importer bought 92,300 MT in Thursday's tender.

Walmart stock ticks up as leadership reshuffle sets stage for CEO handover

January 17, 2026, 4:43 PM EST. Walmart shares rose 0.42% to $119.70 after a broad leadership shake-up as John Furner prepares to take the CEO helm Feb. 1. He will oversee a reorganization that creates roles for David Guggina (President/CEO, Walmart U.S.), Chris Nicholas (CEO, Walmart International) and Latriece Watkins (CEO, Sam's Club). Kathryn McLay will exit Walmart International by January end and depart April 30. The changes were disclosed in an amended 8-K filing with the SEC. An 8-K is a company-reporting form for material events. Furner's compensation includes a $1.5 million base salary, a one-time stock award around $10 million, and an estimated $17 million in annual equity in fiscal 2027. Nasdaq-100 index changes move Walmart into AstraZeneca's spot ahead of Tuesday's open; Walmart reports fiscal Q4 results Feb. 19.

WiseTech Global's CargoWise rollout and new pricing reshape investment narrative

January 17, 2026, 4:41 PM EST. Analysts have grown more positive on WiseTech Global as CargoWise rollout accelerates and the company tests a new per-transaction, Value Pack pricing model. The narrative centers on whether deeper adoption and a refreshed commercial approach will lift revenue mix while managing churn risk from pricing changes. Six months to December 31, 2024 reported revenue of US$381 million and net income of US$106.4 million, with a fully franked interim dividend of 6.7 cents per share; guidance was revised lower at the bottom end due to delays in Breakthrough Products. The bull case hinges on faster CargoWise expansion and a successful transition to per-transaction pricing, potentially lifting revenue toward US$2.0 billion and earnings to nearly US$487 million by 2028.

QCLN AI-Generated Signals: Buy near 15.93, stop 15.85

January 17, 2026, 4:25 PM EST. January 17, 2026 report on First Trust NASDAQ Clean Edge Green Energy ETF (QCLN:CA) shows AI-generated signals. The recommended long plan is to buy near 15.93 with a stop loss at 15.85; no short positions are offered. The piece notes updated AI-generated signals for QCLN:CA and lists Near, Mid, and Long-term ratings as Strong, Weak, and Neutral. It emphasizes checking the timestamp and chart for context. The tone remains factual and concise, delivering actionable points without speculation and in line with market-reporting rhythm.

SiriusPoint Valuation Under Scrutiny After Share-Price Softness, MGA Growth Outlook

January 17, 2026, 4:10 PM EST. SPNT closed at $20.00, down 1.9%. One-month returns are -8.9%, but 90-day gains reach +13.4% and 1-year TSR is +33.4%, signaling weaker near term momentum but solid longer-term gains. A value score of 3, an intrinsic discount of 6.6%, and a 25% gap to analysts support a potential upside to a fair value around $27.50. At current levels, valuation suggests the market may be pricing in part of a recovery. The stock's expanding MGA partnerships in international and London markets, plus a tendency to retain more net risk, could lift both fee-based and underwriting income as these relationships scale. Risks include underperforming MGA deals, reserve trends, and catastrophe losses. The P/E stands at 12.6x vs US insurance avg 12.8x, implying possible upside if sentiment improves.

Sugar climbs on fund short-covering ahead of MLK weekend; India, Brazil output weigh on outlook

January 17, 2026, 4:09 PM EST.Sugar prices rose as funds covered short bets ahead of a US three-day weekend for Martin Luther King Day. March NY sugar #11 (SBH26) gained 2.68%, and March London white sugar #5 (SWH26) rose 2.44%. The move followed Thursday's lows, and the weekly Commitment of Traders (COT) report showed funds expanding white sugar net longs by 4,544 to a record 48,203. Fundamental factors remain mixed. India's 2025/26 sugar output climbed about 21% year on year to 15.9 MMT, while Brazil's Center-South output through mid-December rose 0.9% to 40.158 MMT. Analysts see a global sugar surplusCovrig pegged 2025/26 at 4.7 MMT and 2026/27 at 1.4 MMT – though expectations of smaller Brazilian supplies and India's export potential could support prices.

Hitachi stock flagged as overvalued after multi-year gains (TSE:6501)

January 17, 2026, 3:56 PM EST. Hitachi's stock (TSE:6501) closed at ¥5,204, with 7-day returns of 1.3% and 30-day gains of 4.9%; YTD around 2.7%, and about 42.4% over 1 year. The chart shows roughly four times higher price over 3 years, and big gains over 5 years. Simply Wall St scores it 1/6 on undervaluation. Its DCF analysis-using a 2-stage Free Cash Flow to Equity model-yields an intrinsic value of ¥3,591.03 per share, about 44.9% below the current price, signaling OVERVALUED. The stock also trades at a P/E of 29.52x. In short, the valuation backdrop does not fully justify the rally, though momentum remains.

Solventum (SOLV) valuation signals upside as momentum cools; fair value near $85.64

January 17, 2026, 3:55 PM EST. Solventum (SOLV) traded near $79.48, with a one-day gain of 1.19% and a week-long rise of 7.73%. Three-month return stands at 10.14%, while the one-year total shareholder return is 8.12%, suggesting momentum has cooled but not erased. A base case from Simply Wall St shows a fair value around $85.64, implying a ~40% discount to intrinsic value or a modest valuation gap. The stock carries a value score of 5 and a proposed price target about 10% higher. The company's pipeline-Negative Pressure Wound Therapy, advanced wound care, sterilization, and digital health solutions such as autonomous coding-could support long-term top-line and earnings growth amid rising demand for healthcare tech. Risks include the 3M separation, ERP rollout, and SKU rationalization that could weigh on reported growth and margins.

IGO's momentum and webcast plan shape investment narrative in battery minerals era

January 17, 2026, 3:53 PM EST. IGO Ltd's stock has strengthened on ASX technical uptrend signals as the miner gears up for a late-January webcast to review December 2025 results. Lithium prices have fallen and supply appears stabilizing, but investors are focusing more on IGO's role in the battery minerals sector and upcoming disclosures. The market sees momentum in lithium-related equities as a short-term catalyst, even as IGO remains loss-making with forecast revenue contraction and no interim dividend. The webcast is expected to frame cash flows, production guidance and capital allocation following a A$954.6 million loss. Ausbil exited as a substantial holder, reducing but not changing the core risk that valuation relies on future earnings recovery. Near-term funding and earnings risk remains.

Nutanix appears undervalued after price slump, DCF suggests

January 17, 2026, 3:39 PM EST. Nutanix Inc. NTNX closed at $45.74, after a 7-day decline of 14.5% and a year-to-date drop of 9.6%. Seven days aside, three- and five-year returns run 70.7% and 36.5%, but the stock is down 29.8% over the last 12 months. The shares carry a valuation score of 3 out of 6, signaling mixed sentiment about cloud-infrastructure software and subscription models. A two-stage Free Cash Flow to Equity (FCF; cash available to equity holders) model yields an intrinsic value of about $74.61 per share, suggesting ~38.7% undervaluation versus the current price. The model is anchored by a trailing twelve-month FCF of about $773.8 million and projects roughly $1.55 billion in 2035, underscoring the sector's sensitivity to subscription dynamics.

Halliburton Valued After 17% Rally, DCF Indicates Undervaluation

January 17, 2026, 3:38 PM EST.Halliburton (HAL) closed at $32.57 after a 17.4% 30-day rally, with a 12.2% return over the last year. A valuation check scores 4 of 6, showing several signals of potential undervalued status alongside some balanced factors. Using a two-stage Free Cash Flow to Equity model, the latest DCF yields an intrinsic value of about $72.06 per share, implying roughly a 54.8% discount to the current price. That view brands HAL as undervalued on cash-flow grounds. A traditional P/E multiple around 20.9x anchors the earnings argument, placing the stock near energy-services peers. The analysis also links broader energy sentiment to price moves and outlines how investors can reconcile different methods to gauge risk and value.

Alphabet set to beat the market in 2026 but unlikely to replicate 2025 surge

January 17, 2026, 3:21 PM EST. Alphabet, parent of Google, was a top performer in 2025 among the Magnificent Seven, a group of large tech names that surged last year. The unusually strong run may not repeat in 2026, but the stock could still beat the market. Key themes: Gemini, Alphabet's AI model, is winning enterprise adoption; Google Search remains a dominant cash cow, and AI-generated Overviews have helped keep traffic intact. Political risk from antitrust eased after a lighter penalty and no breakup was mandated, while Chrome and Android stay core to the business. A later monetization of AI could lift the multiple, though the near term remains uncertain. The stock hovered around $330 with a roughly $4 trillion market cap as of the latest session.

AI-generated trading signals for Ivanhoe Electric IE:CA show strong ratings; buy/sell levels published

January 17, 2026, 2:36 PM EST. AI-generated signals for Ivanhoe Electric Inc. (IE:CA) were updated on Jan 17, 2026 at 02:02 PM ET. The note, by Thomas H. Kee Jr., Editor of Stock Traders Daily, lists explicit trading plans. On the long side, buy near 21.35 with a target of 24.89 and a stop at 21.24. On the short side, sell near 24.89 with a target of 21.35 and a stop at 25.01. Ratings for near, mid and long terms appear Strong. The report flags AI-generated signals and includes a chart for IE:CA. This is a market signal update, not a formal investment advisory.

Frontier Communications Parent (FYBR) valuation check after price strength

January 17, 2026, 2:19 PM EST. Frontier Communications Parent (FYBR) trades near US$38.49 after a recent price advance. A Simply Wall St review flags a 1.6x price-to-sales (P/S) ratio, above the peer average and the US telecom sector, prompting questions about how much growth is already baked into the price. The stock has returned about 8% over the past year and roughly 34% over three years. The company posted a US$381 million net income loss, underscoring risk if the multiple compresses. A discounted cash flow (DCF) model puts fair value at about US$80.85, implying roughly 52% upside from current levels. Investors should weigh this against profitability trajectory and valuation risks as they gauge Frontier's future path.

Moog (MOG.A) Valuation Appears Fair After DCF Check, But Upside Limited

January 17, 2026, 2:06 PM EST. Moog Inc. trades near $291 after a strong multi-year run, with 6.7% weekly, 19.3% over 30 days, and 292.9% over five years. A Simply Wall St valuation pack gives Moog a 3/6 value score, reflecting mixed signals from different methods. A 2-stage Discounted Cash Flow (DCF) model pegs intrinsic value at about $299.78 per share, versus the $290.80 close, implying roughly a 3% discount and a fair value stance. The model uses Free Cash Flow to Equity (FCFE), with trailing FCF around $103.6 million and forecasts to 2027 of $273.8 million; projections extend to 2035. P/E remains a quick lens on price vs. earnings, but growth and risk shift the balance. In short, Moog looks fairly valued, but near-term catalysts matter.

Medpace Holdings (MEDP) remains attractive after 81% surge, but valuation flags persist

January 17, 2026, 2:05 PM EST. Medpace Holdings (MEDP) has climbed 81% over the past year, trading near $610.90 as investors weigh growth versus risk. Over the last 7 days the stock rose 2.7% and 30 days 9.7%; year-to-date 7.0%. The 5-year return sits at ~330%, with 3-year gains of about 166%. A valuation check by Simply Wall St assigns MEDP a 1/6 score for being undervalued. The centerpiece is a Discounted Cash Flow (DCF) analysis, using a 2-stage free cash flow to equity model, which puts an intrinsic value around $731.59 per share-roughly a 16.5% discount to the $610.90 price, suggesting the stock is undervalued on this metric. The stock trades at a P/E of 39.75x, above the industry average of about 37.46x and peers at 31.90x, tempering the case for value.

ReNew Energy Global fair value pegged at US$7.95 as stock slides to US$5.38

January 17, 2026, 2:04 PM EST. ReNew Energy Global (RNW) faces renewed investor scrutiny after a 30% decline over the last 90 days and a 21% slide in the past year, with the stock around US$5.38. A recent fair-value view places the target at US$7.95, suggesting the shares are undervalued on long-term earnings. The 12-month picture shows 15.1% revenue growth but a 10.1% drop in net income, underscoring margin pressures. Bulls point to expansion of its manufacturing footprint, marquee backers such as British International Investments, and a new 4 GW TOPCon facility that could lift earnings visibility. Risks include tighter competition in project bidding and potential delays. The current P/E of about 21x sits above the 16.8x renewable-energy average, signaling valuation risk if sentiment weakens.

EVEX valuation flags a deep discount to DCF fair value after three-year slide

January 17, 2026, 2:03 PM EST. Eve Holding (EVEX) last traded at $4.52, down 38.4% over three years as interest in early-stage electric aviation ebbs and flows. Simply Wall St's valuation score is 2/6. The DCF model, using a two-stage free cash flow to equity approach, shows a latest 12-month free cash flow loss of $182.843 million, with forecasts turning positive by 2030. Discounting those cash flows yields an intrinsic value around $27.06 per share, implying the stock is undervalued by about 83% versus the market price. The analysis also notes how P/B can be used with non-profitable firms, though its guidance is less clear for EVEX until earnings turn positive. Traders weigh the gap between price and cash-flow-driven value amid volatile funding for electric aviation.

CRH reassessed after share-price pullback; DCF points to modest overvaluation

January 17, 2026, 1:49 PM EST. CRH trades around $122.97 after a mixed week. The shares are down 6.4% over the last week but up about 27.2% in the past year and 196.9% over three years. Our simple valuation flags CRH at 2/6. A Discounted Cash Flow (DCF) model yields an intrinsic value of about $112.86, implying the stock is roughly 9% overvalued at current levels. The analysis notes a narrative around construction materials and infrastructure demand as a driver, while risk and return trade-offs remain in focus. The piece also explains how different valuation methods can converge on a fair value, with caveats about assumptions. Investors may want to monitor price moves and update dashboards as new data arrives.

Ramsey: The secrets of the rich aren't secrets; invest simply in what you know

January 17, 2026, 1:32 PM EST. On The Ramsey Show, Dave Ramsey argues that the so-called secrets of the rich are not secret. Wealth, he says, rests on simple, familiar bets and focusing on what you understand. He cites a $200 million rancher who concentrates on farmland to show wealth can come from expertise, not gimmicks. Ramsey warns against chasing trendy investments or following friends who lack transparency, citing Bernie Madoff as a cautionary example. He endorses the KISS principle and sticks to three core investments: his business, paid-for real estate, and mutual funds. He rejects single stocks, gold, and crypto as speculative. The approach echoes Peter Lynch's adage to buy what you know; Lynch's Magellan fund grew from $20 million to $14 billion AUM.

Two AI Stocks Set to Beat the Market in 2026: Nvidia and Meta Platforms

January 17, 2026, 1:31 PM EST. Two AI stock ideas for 2026: Nvidia and Meta Platforms. Nvidia remains the dominant supplier of AI chips, with data-center demand driving revenue. In the third quarter, Nvidia reported revenue of $57 billion, and guided to about $65 billion in the current quarter, up ~14%; adjusted operating profit rose 25%. Analysts expect earnings to grow substantially this year, supporting a forward multiple around 25x. Nvidia's Vera RubinAI platform, backed by seven chips, is expected to be deployed by major cloud providers, signaling long-term AI infrastructure growth. Meta Platforms is highlighted for its ability to convert AI investments into revenue, leveraging more than 3.5 billion daily active users across Instagram and Facebook to monetize AI-enabled features and ads. The S&P 500 rose; these names offer exposure to AI megatrends, though risks include spending cycles in data centers.

Willis Towers Watson Valuation Post-Move: Fair Value Around $369 vs $329 Close

January 17, 2026, 1:17 PM EST. Willis Towers Watson (WTW) drew fresh attention after a recent price move. The stock closed at $329.41. The one-day gain was 0.28%, with a year-to-date return of 0.96% and five-year TSR of 70.38%, suggesting longer-term momentum. A fair-value view places WTW at about $369.16 per share, implying the stock is undervalued relative to current levels. The market trades at a P/E ratio of 14.9x, above the US Insurance sector 12.8x but below the peer average of 29.5x, signaling limited further upside if earnings slip. The case rests on growth in advisory demand, recurring fee streams, and higher earnings in the mid-term, supported by disciplined costs, divestitures, and investments in high-growth regions. Risks include tougher competition, integration costs, and margin pressures.

Dunelm Group fair value trimmed; analysts split on growth and re-rating risk (LSE: DNLM)

January 17, 2026, 1:16 PM EST. Dunelm Group's fair value estimate was trimmed to £12.21 a share from £12.87 as analysts balance upbeat mid-term guidance with questions about growth durability. The revision reflects a tug-of-war in research: some banks reaffirm guidance and upgrade to Outperform, while others stay Hold or Neutral and flag uncertainty around whether the gains are fully priced in. RBC Capital lifts the target to 1,300 GBp and argues growth acceleration; Jefferies maintains Hold with a higher target, citing margin expansion and solid trading momentum. Panmure Liberum turns cautious with a downgrade; JPMorgan sticks to Neutral while nudging targets. The shift frames Dunelm's narrative around execution, margin delivery, and the scope for further re-rating. Track how these targets evolve to gauge momentum.

AI-generated signals highlight trading plan for Manulife Smart Defensive Equity ETF (CDEF:CA)

January 17, 2026, 1:15 PM EST. AI-generated signals for Manulife Smart Defensive Equity ETF (CDEF:CA) surface a cautious near-term stance. The trading plan remains long-oriented: buy near 12.00 with a stop at 11.94; no short positions are offered at this time. The accompanying ratings split across horizons: near-term strong, mid-term weak, long-term strong. The data is time-stamped Jan 17, 2026, 12:50 PM ET, and notes that updated AI-generated signals are available for review. The report, authored by Rick W. with editor Derek Curry, emphasizes checking the timestamp and caveats around AI-generated guidance. Investors should consider the long-term context of the ETF, while monitoring price action around the 12.00 level and the 11.94 stop.

Bank of Hawaii valuation: momentum tests fair value near price

January 17, 2026, 1:00 PM EST. Bank of Hawaii trades at $71.25, with an intrinsic value of about $74, implying a 44.6% discount to the stated fair value and a near-term upside of roughly 3.9%. A recent price move left the stock up 0.85% on the day, while 90-day returns of about 16.6% contrast with a 1-year total shareholder return near 4.2%. Analysts model revenue rising about 9% a year over the next three years, supported by margins that could lift earnings multiples for banks. The bear case rests on Hawaii's real estate cycle and higher funding costs that could compress net interest margins. The full narrative walks through earnings paths, valuation math, and the assumptions behind the $74 fair value. Investors can adjust the thesis with Do it your way or screen for other opportunities.

Microsoft stock faces Musk's $134 billion claim ahead of Jan. 28 earnings

January 17, 2026, 12:48 PM EST. Microsoft (MSFT) shares closed Friday at $459.86, up 0.7% but down about 3.6% for the week as Elon Musk pursues as much as $134 billion in a lawsuit alleging wrongful gains by OpenAI and Microsoft. Musk told a federal court OpenAI revenue was pegged at $65.5-$109.4 billion and Microsoft at $13.3-$25.1 billion; a jury trial is set for April. Markets will be closed for Martin Luther King Jr. Day, delaying the next session to Tuesday. The broader backdrop remains macro jitters that have weighed on megacap tech on rate and policy moves. Probes into Activision Blizzard's sales tactics were announced, and Wikimedia said it will compensate firms using Wikipedia to train AI. Microsoft also struck a carbon-credit deal with Indigo Carbon, estimated at $171-$228 million.

Tradeweb Markets: The fintech stock you'll hear about

January 17, 2026, 12:46 PM EST. Tradeweb Markets operates a global network of electronic marketplaces that underpin institutional trading across four asset classes. Unlike consumer-facing brokers, Tradeweb is not a household name, but it's become essential to the smooth functioning of financial markets. The company's platforms focus on rate-related fixed income-sovereign debt, mortgage-backed bonds, and swap contracts on rate indexes; credit-corporate and municipal bonds and credit default swaps; equity via ETFs and related options; and money markets-including certificates of deposit, money market funds, and repos. It also supplies market data to institutions. While it serves equity investors only through ETFs, it supports dealers, treasurers, and other institutional clients with faster, more transparent trading. In more than 25 years, Tradeweb has established leadership in electronic trading.

ProPetro Holding (PUMP) undervalued on DCF as shares rebound

January 17, 2026, 12:45 PM EST. ProPetro Holding Corp (PUMP) looks undervalued in a DCF check. The model assigns an intrinsic value of $134.39 per share, implying the stock is about 92.3% undervalued versus its current price. Shares rose 9.4% in the past week and 13.8% over 30 days, with a 4.8% year-to-date gain, 10.6% over 3 years and 23.8% over 5 years; the 1-year return is -5.6%. The latest twelve months show a free cash flow loss of $19.96 million; projections extend a decade, moving from a $93 million loss in 2026 to a $946.58 million loss in 2035. On a cross-check, the stock's P/S ratio is 0.83x, vs. the Energy Services industry average of 1.20x; peer group average sits higher at 1.

Definium Therapeutics (DFTX) Undervalued by DCF After 1-Year 110% Surge

January 17, 2026, 12:44 PM EST. Definium Therapeutics (DFTX) has jumped about 110% over the past year and trades around $15.05. A Simply Wall St valuation snapshot gives a 2/6 score, signalling limited undervaluation from some checks. The report applies a 2-stage Free Cash Flow to Equity (FCFE)Discounted Cash Flow (DCF) model. It projects negative FCF in the last 12 months and an eventual positive stream through 2030, yielding an intrinsic value of about $234.95 per share. Compared with the current price, that implies the stock is roughly 93.6% undervalued under this setup. The takeaway: momentum may outpace fundamentals, but the base-case relies on volatile profits and pipeline milestones. Investors should weigh the potential value against risk factors and biotech sector dynamics.

VOO vs VTI: Weighing large-cap focus against the total stock market

January 17, 2026, 12:30 PM EST. Choosing between VOO and VTI comes down to view on small-caps. VOO tracks the S&P 500-roughly 500 of the largest U.S. companies-with heavy megacap tech weightings. VTI covers those firms and more than 3,500 additional stocks across large-, mid-, and small-cap. Expense ratios are both 0.03%. Over five years, the S&P 500 averaged 14.45%, versus 13.05% for the Total Stock Market ETF, a small gap driven by tech-led gains. Recently, large-cap leadership narrowed as the cycle shifted and small caps weighed on performance. In early 2026, the S&P 500 ETF lagged the broader market year-to-date. For the long run, both are solid options; the choice hinges on whether you want small caps in your portfolio.

Two growth stocks to buy and hold for 10 years: Robinhood and HCA Healthcare

January 17, 2026, 12:29 PM EST. Investors looking a decade ahead avoid bets tied to short-term noise. The piece weighs two growth names: Robinhood Markets and HCA Healthcare as long-term holdings. Robinhood has driven revenue and earnings higher in recent years, but it faces a steep forward earnings multiple of about 46.5 and exposure to cryptocurrency trading, which can swing with crypto cycles. Still, its appeal endures: strong appeal among younger investors, a modern app, and ongoing product expansion. Initiatives such as Robinhood Legend, AI trading tools, and a growing Robinhood Gold subscription offer recurring, higher-margin revenue. The analysis suggests these drivers could support solid results through the next decade, even as valuation and crypto exposure temper the outlook. The piece emphasizes that a 10-year horizon helps manage risks and capture potential outperformance.

Andlauer Healthcare Group AND:CA – AI-generated signals and trading plans

January 17, 2026, 12:28 PM EST.AI-generated signals for Andlauer Healthcare Group Inc. Subordinate Voting Shares (AND:CA) were published Jan. 17, with an updated timestamp. The note presents two trading plans: a long entry near 51.41 with a target of 55.46 and a stop at 51.15; and a short entry near 55.46 with a target of 51.41 and a stop at 55.74. The update also lists ratings for AND:CA across Near, Mid, and Long horizons, ranging from Neutral to Strong. A chart for AND:CA accompanies the report, and readers are advised to check the data timestamp. The piece follows a market-brief cadence with concrete levels, defined risk points, and mentions AI-generated signals as decision-support.

PSLV.U:CA AI-generated signals flag near-term buy at 11.66 for Sprott Physical Silver Trust

January 17, 2026, 12:12 PM EST. AI-generated signals for PSLV.U:CA flag a near-term buy for Sprott Physical Silver Trust. Traders are advised to buy near 11.66, with a stop at 11.60. No short positions are offered at this time. The timestamp is 11:54 AM ET, January 17, 2026. Ratings by term show Near-term: Strong, Mid-term: Weak, Long-term: Neutral. The signals accompany updated materials for PSLV.U:CA and form part of an ongoing AI-driven set of recommendations. No target price is published for the longer horizon; market participants should watch the entry near the suggested level and adjust risk controls accordingly.

Amazon poised for a 2026 rebound as AWS margins and ad growth support a revival

January 17, 2026, 11:57 AM EST. Amazon's 2025 performance lagged the Magnificent Seven, but investors see a rebound in 2026. After a year when the S&P 500 rose roughly 16%, Nasdaq up over 20%, and the Dow near 13%, Amazon gained about 5% in 2025-the weakest among the group. The company has used robotics and automation to shave costs and lift efficiency; Morgan Stanley projects nearly 40 fulfillment centers with robots, potentially saving up to $4 billion. The focus shifts beyond e-commerce to AWS, which accounted for about 18% of revenue but more than 65% of operating income in Q3. Advertising remains the fastest-growing, high-margin segment, up 24% year over year, ahead of AWS (20%), third-party seller services (12%), and other lines. In short, a 2026 revival case hinges on margins, ad growth, and AWS profitability.

Blue Bird (BLBD) seen undervalued by DCF despite multi-year rally

January 17, 2026, 11:42 AM EST. Blue Bird (BLBD) trades around $49.03 after a multi-year rally. The stock has: 1.2% higher in the last week, 5.3% lower in 30 days, 4.9% higher year to date, and 19.7% over the past year. A Discounted Cash Flow model yields an intrinsic value of about $93.51 per share, implying the price is undervalued by about 47.6%. The model uses a 2-stage Free Cash Flow to Equity approach; latest twelve-month FCF is about $158.8 million, with forecasts ranging from $40.3 million in 2026 to $222.9 million in 2035. It also notes a valuation score of 6/6. In summary, the stock's current price sits well below the cash-flow-based fair value, suggesting upside if growth and capital-goods sentiment improve.

Five TSX Stocks to Hold for the Next Decade

January 17, 2026, 11:30 AM EST. The Motley Fool Canada argues five TSX stocks offer durable franchises for the next decade. RBC anchors Canadian portfolios. As the country's largest bank, it benefits from scale, diversification and steady dividend growth, though its P/E trades near 2010 levels, suggesting a pullback entry may be prudent. CNQ stands out in a resilient energy mix, with long-life reserves and disciplined capital allocation; it pays about a 5.3% dividend and traded around $44.62 at writing, roughly 15% below consensus target. BIP.UN owns inflation-linked cash flows across utilities, pipelines and data centres, with a roughly 5.0% yield and a 14% discount to fair value. BAM leans on an asset-light model in alternative assets, positioning for long-term growth as investors lean into real assets. The fifth stock isn't named in the excerpt.

Uber vs Coca-Cola: Which Stock Looks Best to Buy Now

January 17, 2026, 11:28 AM EST. Both Uber and Coca-Cola posted double-digit gains in 2025. Uber, with a roughly $177 billion market cap, surged about 35% in the year and expanded its ecosystem through ride-hailing and delivery, supported by group bookings of $25.1 billion in Q3 (the gross value of orders) and a 25% year-over-year rise in delivery bookings. The company notes only about 15% of U.S. adults use Uber, leaving room for cross-selling and adoption, plus a growing ad business with a run rate near $1.5 billion. Coca-Cola, a far older and more stable franchise, dominates beverages with 200+ brands and 2.2 billion daily servings; it delivered 16% total return in 2025, underscoring its durability. Investors face a tradeoff: growth potential at Uber versus defensive cash flow at Coca-Cola. Choice depends on risk tolerance and time horizon.

Buffett indicator at record high as S&P 500 climbs in 2026

January 17, 2026, 11:27 AM EST. The S&P 500 has risen about 21% in the past 12 months and roughly 41% from its April low last year. A popular gauge, the Buffett indicator-the ratio of U.S. stock market capitalization to GDP-sits around 222%, a level last seen before the 2021 bear market. No metric is perfect, and a recession or bear market is not guaranteed. Still, the reading could warn investors to exercise caution. Prepare portfolios by focusing on solid, long-term growth companies, and consider trimming or exiting weak stocks while prices surge. In short, preparation matters more than precise timing as downturns arrive unpredictably.

TSMC's AI-chip dominance keeps stock appealing at $1.8 trillion market cap

January 17, 2026, 11:26 AM EST. TSMC sits among a handful of companies with a market cap above $1 trillion, now near $1.8 trillion after a 2025 rally. The stock's strength tracks demand for AI chips and a shift to HPC-the high-performance computing segment that now dominates its revenue. In Q3 2025, HPC brought in about $18.87 billion, more than the total in 2021. TSMC operates as a foundry, producing chips for clients like Apple rather than selling designs. Even if AI demand cools, the mix spans smartphones, computers, cars and more, supporting a durable core. The article argues the valuation is high but the fundamentals justify a buy stance for patient investors.

Hitachi Construction Machinery (TSE:6305) appears undervalued after a strong run, according to a DCF that suggests ~28% upside

January 17, 2026, 11:25 AM EST. Hitachi Construction Machinery closed at ¥5,421 after a 7.8% weekly rise, with a 1-year return of 59.6%. Over 3 years and 5 years, the stock is up about 105.6% and 100.6%, deepening valuation questions. Simply Wall St uses a 6-point framework and gives the stock 5/6 on valuation. A two-stage Free Cash Flow to Equity model puts the intrinsic value at about ¥7,553 per share, implying roughly 28.2% upside to today's price. In short, the stock looks undervalued on this DCF view. DCF, or discounted cash flow, projects future cash flows and discounts them to present value. Investors will watch for shifts in project pipelines and balance sheets that could re-rate the shares toward intrinsic value.

DHT.UN:AI-generated trading signals for DRI Healthcare Trust (DHT.UN:CA)

January 17, 2026, 11:10 AM EST. AI-generated signals for DHT.UN:CA (DRI Healthcare Trust) were published Jan 17, 2026. The plan lays out a long-term trading approach: buy near 15.59 with a target of 16.54 and a stop at 15.51. A short setup sits at 16.54, with a target of 15.59 and a stop at 16.62. Ratings for the term structure show near-term: Weak; mid-term: Neutral; long-term: Strong. The report notes the data come from an AI model and includes the timestamp. This is a trading signal, not a guarantee; investors should cross-check with other analysis.

AI-generated signals for CCOE:CA show buy near 16.23; Near/Mid strong, Long neutral

January 17, 2026, 10:58 AM EST. AI-generated signals for the Harvest Cameco Enhanced High Income Shares ETF, ticker CCOE:CA, were updated Jan 17, 2026. The plan lists a buy near 16.23 with a stop at 16.15; no target is given. No short positions are offered. For Jan 17, the Near and Mid terms are rated Strong, while the Long term is Neutral. The data originate from an AI-generated system and are published by Bill T., contributor, under Editor Derek Curry. Note the timestamp and that the signals reflect AI guidance. The ETF's chart page shows the current signal status for CCOE:CA.

Bank of America names five stocks to buy ahead of earnings, including Amazon

January 17, 2026, 10:57 AM EST. Bank of America named five stocks it sees as best positioned heading into earnings, including Amazon. The bank points to AWS revenue growth and AI catalysts as upside drivers, arguing Amazon could see multiple expansion as it scales AI and retail efficiency. Other buy-rated names highlighted by CNBC Pro include Brookdale Senior Living, Carvana, Corning, and Vertiv. Analyst Joanna Gajuk upgraded Brookdale to Buy, citing improving occupancy and 15%+ adj. EBITDA growth with limited exposure to government payors; Brookdale reports in late February and has risen ~13% this year. For Carvana, a higher price target reflects TAM expansion; Corning benefits from a balanced glass market and AI-driven demand; Vertiv should gain from margin recovery and AI-adoption in data centers.

Ashtrom Group trades well above modeled value after multi-year gains

January 17, 2026, 10:56 AM EST. Is Ashtrom Group (TASE:ASHG) priced attractively? At about ₪80.14, the stock's multi-year gains shadow the valuation case. Simply Wall St assigns a valuation score of 1/6, a signal the stock may be richer than fundamentals. The Dividend Discount Model (DDM) yields an intrinsic value of about ₪8.54 per share, meaning the current price sits roughly eight times that value and marks the stock as overvalued. The model assumes a payout of about 34%, ROE of 5.09%, and a long-term dividend growth input around 3.16%. In short, investors are weighing price against fundamentals as the market prices in growth and risk. The full valuation breakdown may surface additional red flags and peer context.

Centuri Holdings (CTRI) Valuation in Focus After Momentum: P/S vs. DCF Signals

January 17, 2026, 10:55 AM EST. Centuri Holdings (CTRI) has drawn buyers after a rally, with shares at $27.80 and a 90-day return of 38.24%. The stock trades at about 1x price-to-sales, above the estimated fair P/S of 0.8x and below the wider US Construction industry average of 1.3x, signaling cautious pricing. A one-year total return of 27.17% underscores momentum, but fundamentals remain thin: net income of $2.514 million on $2.841 billion revenue. A near-term risk is that the shares trade above the $25.50 analyst target. A DCF model suggests a fair value around $16.82, implying the stock is overvalued on that basis. Investors should weigh growth forecasts around 8.5% and insider ownership against valuation signals and market sentiment.

Dollar Tree may be overvalued after 94% rally, DCF analysis shows

January 17, 2026, 10:44 AM EST.Dollar Tree (DLTR) closed at $139.95, after a 94% rally over the last year. The stock has chalked up 5.7% in the past week, 9.0% in 30 days, and 9.6% year-to-date, with a three-year decline of about 5.3% and a five-year gain near 29.7%. Simply Wall St. assigns a 0/6 score on its valuation checks, flagging questions about value. The firm uses a 2-stage Free Cash Flow to Equity (DCF) model; latest twelve-month FCF is about $1.44 billion. The model yields an intrinsic value of about $110.81 per share, implying the price is roughly 26.3% above fair value and the stock is overvalued relative to this estimate.

Morningstar stock looks overvalued after 34% year-long drop, per Excess Returns model

January 17, 2026, 10:42 AM EST. Morningstar's shares hover around US$213.91 after a 34.1% retreat in the last year. An Excess Returns valuation yields an intrinsic value of about US$99.89 per share, implying the stock is roughly 114.1% overvalued at current levels. The calculation uses a Book Value of US$36.48, Stable EPS of US$6.47, an average ROE of 15.39%, and a Cost of Equity of US$3.52, with an Excess Return of US$2.95. A Stable Book Value of US$42.05 per share from two analysts rounds out the inputs. The report notes Morningstar's recurring revenue, brand strength, and product mix, but says the price largely reflects higher growth expectations. It also flags a 3/6 on valuation checks and mentions P/E as a quick earnings proxy. Investors weigh long-term potential against recent price action and risk.

Brown-Forman appears undervalued after multi-year price weakness, per DCF model

January 17, 2026, 10:40 AM EST. Brown-Forman trades at $26.40 after a 7-day gain of 1.7%, but a 30-day slide of 8.5% leaves the stock down about 20.7% over the past year. A multi-model look at value shows a disconnect between price and what the business could earn. A Discounted Cash Flow (DCF) model returns an intrinsic value near $42 per share, suggesting the shares are undervalued by roughly 37%. Simply Wall St's 6-point framework also flags the stock as undervalued (5 of 6). The analysis notes how investor expectations are shifting around brand strength, growth potential, and risk for Brown-Forman's mature spirits portfolio, helping explain why price moves have not been linear.

Elevra Lithium (ASX:ELV) rises on staged NAL debottlenecking plan to accelerate output

January 17, 2026, 10:38 AM EST. Elevra Lithium surged 6.2% after January 2026 plans for its North American Lithium (NAL) mine outlined a staged debottlenecking strategy. The company aims to accelerate permitting, lift spodumene concentrate output by about two years and phase capex while pushing lower unit operating costs. The plan prioritises low-risk brownfield debottlenecking – using existing permits and temporary mobile crushing to raise milling capacity before a full new crushing and ore-sorting circuit. Management argues the approach could sharpen near-term catalysts: progress toward the 315 ktpa target and clearer cash costs visibility. The move supports an investment narrative that links move from loss-making growth toward disciplined, lower-cost production, even as Elevra remains in transition with a new CFO and board. Analysts flag potential impacts from new cost reporting on margins. The stock reaction signals market optimism but risks remain.

Kering (ENXTPA:KER) Valuation Check After Share-Price Weakness and Mixed Returns

January 17, 2026, 10:24 AM EST.Kering (ENXTPA:KER) has faced renewed pressure as shares weaken. The luxury group's stock slid 4.21% in the latest session, with momentum fading over the past week, month and three months, though the 1-year total return remains positive at 22.07%. The valuation shows a P/E around 48.6x, near peers at about 53.8x. The market implies a Fair Value of €296.45 versus a last close of €288.70, a small gap. Analysts' targets range from €135.0 to €360.0, with a consensus near €200.65. Risks include revenue declines across key brands and ongoing store closures, which could pressure margins. A roughly 2.6% undervaluation signal persists, modest in the face of the earnings multiple.

Stephens trims Global Payments target to $90 as outlook turns cautious for GPN

January 17, 2026, 10:23 AM EST. Stephens cut Global Payments' price target from $95 to $90, citing a cautious outlook. The firm keeps an equal weight rating, with a target implying about a 21.92% upside from Friday's close. Analysts are mixed. Cowenhold; TD Cowen trims to $90 and holds; Citigroup lifts to strong buy; Jefferies drops to $75 with a hold; KeyCorp moves to sector weight from overweight. MarketBeat shows three Strong Buy, seven Buy, fifteen Hold, one Sell; consensus target $98.62. The stock opened at $73.82 and is down about 1.6%. Market cap about $17.5B; P/E 10.37, PEG 0.63, beta 0.79. One-year range $65.93-$114.17. Q3 EPS $3.26 on $2.43B revenue; FY25 guidance $6.60-$6.66; current-year EPS $11.89. Insider Connie D. Mcdaniel sold 4,464 shares at $77.81.

Recursion Pharmaceuticals (RXRX) seen undervalued after DCF signals amid price weakness

January 17, 2026, 10:13 AM EST.Recursion Pharmaceuticals (RXRX) closed at $4.67 as shares show weakness. Over the last 7 days the stock rose 0.2%, and in the past 30 days it fell 0.2%, with a 11.2% year-to-date gain but a 28.5% drop over the last year. The market weighs its development model against traditional checks. A two-stage Free Cash Flow to Equity model yields an intrinsic value of about $9.31 per share, suggesting the stock is roughly undervalued at current prices. The analysis also considers P/B (price-to-book), noting that P/B reflects growth expectations and risk. Investors are reassessing whether the current price fairly reflects Recursion's prospects as discussions of its drug-discovery approach continue.

PNC.B: AI Signals Show Weak Ratings; Trading Plans Define Tight Entry/Exit Levels

January 17, 2026, 10:12 AM EST. On January 17, 2026, AI-generated signals for Postmedia Network Canada Corp. Class NC Variable Voting Shares (PNC.B:CA) were updated. Ratings for PNC.B:CA across terms are Weak in the Near, Mid, and Long horizons. The trading plan lays out a Long entry: Buy near 0.84, target 1.01, stop loss 0.84. A Short setup: near 1.01, target 0.84, stop loss 1.02. Readers are reminded to check the timestamp; a chart is referenced. The signals stem from an AI-generated system for Postmedia Network Canada Corp. Class NC Variable Voting Shares, with the chart link noted as available.

Jacobs Solutions appears undervalued after multi-year rally, DCF implies ~40% gap

January 17, 2026, 10:11 AM EST. Jacobs Solutions trades near $139.94 a share after a strong multi-year run. It has risen 44.8% and 58.8% over the last three and five years. A Discounted Cash Flow (DCF) model, which estimates intrinsic value by discounting projected cash flows, yields about $232.87 per share, implying roughly a 39.9% undervaluation. It uses a two-stage Free Cash Flow to Equity (FCFE) projection, with 2035 FCFE around $1,622.5m. The stock trades on a P/E of 52.6x, above the Professional Services group, and the source rates the valuation 2/6. Market attention to backlog and contract visibility can drive pricing, leaving the overall case mixed.

CIBC valuation flags undervaluation after rally, says Excess Returns model

January 17, 2026, 10:10 AM EST. CIBC trades at CA$128.46 on the TSX, up 1.7% in 7 days and 47.4% over the last year. Simply Wall St flags a mixed picture: a 3/6 valuation score and an intrinsic value around CA$185.55 per share, a roughly 30.8% discount to price. The Excess Returns framework uses book value CA$67.37, stable value CA$70.09, stable EPS CA$10.18, and a cost of equity CA$5.04 to derive value. Return on equity is forecast near 14.5%. The analysis notes sector risk from capital requirements, loan quality, and higher funding costs. In short, the rally looks stretched relative to fundamentals, though the stock shows potential if earnings and capital dynamics hold.

Hewlett Packard Enterprise stock appears undervalued after pullback, DCF fair value at $34.49

January 17, 2026, 10:09 AM EST. Shares of Hewlett Packard Enterprise closed at US$21.44, down about 3.3% last week, 10.7% over the past month and 11.3% year to date. The move comes as analysts and investors monitor HPE's role as an enterprise technology provider and the sensitivity of its stock to IT spending cycles. Simply Wall St rates the stock at 6 out of 6 in its valuation checks. A two-stage Discounted Cash Flow model based on free cash flow projects a fair value of US$34.49 per share, implying the stock trades about 37.8% below intrinsic value. The piece also weighs the Price-to-Sales approach as a valuation lens, highlighting growth and risk as key drivers. The narrative suggests HPE could be undervalued given cash flow potential, though valuation depends on assumptions about future spending.

NXDT three-year returns remain weak; TSR cushions decline via dividends

January 17, 2026, 10:08 AM EST. NXDT, the NexPoint Diversified Real Estate Trust, posted a 16% gain in the latest quarter but three-year results remain weak. The shares are down about 68% over three years, while revenue has fallen about 3.5% per year and the firm has been unprofitable over the past 12 months. If growth returns, it could help, but the topline decline complicates an earnings case. Insiders have been buying over the last year, a possible sign of confidence that isn't guaranteed. For perspective, total shareholder return, or TSR (which includes reinvested dividends), fell 56% in three years — a better result than the price move thanks to distributions. In the past year, the broader market rose about 17%; NXDT lost roughly 16%.

Leerink lifts Danaher price target to $270; stock set for upside

January 17, 2026, 10:07 AM EST. Leerink Partners lifted Danaher's price target to $270 from $260 and kept an outperform rating, signaling roughly 14% upside from the prior close, the firm said. The report comes as Bank of America trimmed its target to $220, Deutsche Bank raised to $250, Argus set $265, and Goldman Sachs initiated with a Buy and $265; Robert W. Baird offered $247. MarketBeat shows a consensus Moderate Buy at about $252.83 from 21 Buy and 5 Hold ratings. Danaher opened at $236.05; the 52-week range spans $171.00 to $258.23. Key metrics cited include a high P/E around 48.7 and a market cap near $167 billion. Q3 earnings were $1.89 per share on revenue of $6.05 billion, beating estimates; margin stood at 14.44%. An insider sold 5,174 shares for roughly $1.09 million.

Brace for a stock-market pullback: practical steps to weather a crash

January 17, 2026, 9:57 AM EST. Investors are warned that a market crash is not a question of if but when. Analysts say 30% sell-offs occur roughly every decade in both the TSX and S&P 500; 40% declines are rarer, and halving the market has happened only twice this century, around dot-com and the 2008 crisis. Amid chatter that 2026 could bring a repricing of AI gains, advisers urge calm. The guiding rules: use dollar-cost averaging to deploy a fixed amount at regular intervals; stay invested to avoid locking in losses; treat downturns as a fire-sale buying opportunity rather than a reason to panic. The Buffett reference underscores the idea: market dips let you buy America's future at lower prices. The article stresses discipline and regular contributions to endure the cycle.

Dongjiang Environmental forecasts deeper 2025 loss as industry restructures

January 17, 2026, 9:56 AM EST. Dongjiang Environmental expects a deeper net loss for 2025, guiding RMB1.05-1.35 billion, versus about RMB804 million in the prior year, with basic loss per share of RMB0.95-1.22. Management pins the deterioration on fierce competition and margin compression in core non-hazardous treatment and recycling businesses, plus asset and credit impairment provisions. A sustainable earnings rebound will take time as the group presses a strategic shift toward technology-driven resource recycling, utilization and integrated environmental services. The latest analyst takeaway is a Hold with a HK$2.00 price target. Dongjiang is a PRC-incorporated environmental services company listed in Hong Kong, operating in hazardous and non-hazardous waste treatment and aiming to build a full renewable-resource recycling chain.

Organon (OGN) undervalued after price weakness; DCF signals about 88% upside

January 17, 2026, 9:54 AM EST.Organon (OGN) trades at $8.76 after a choppy year. Its shares gained about 8.8% last week and 25.3% in the past month, but remain down 42.9% over 12 months and 67.6% over three years. On Simply Wall St's valuation checks, Organon scores 5 out of 6 for being undervalued. A two-stage Free Cash Flow to Equity (FCFE) model pins an intrinsic value of about $74.85 per share, implying roughly 88.3% upside from the current price. The latest twelve-month free cash flow is about $639 million; projections rise to $1,350 million by 2030, extending to 2035 with moderating growth. The result: a potential disconnect between price and cash flows, though investors should weigh growth, risk and the P/E framework within the broader sector context.

Banner (BANR) Valuation Signals Undervaluation as Momentum Cools

January 17, 2026, 9:53 AM EST. Banner (BANR) trades near $64.87 after a mixed momentum spell, with a 1-day decline of about 1.65% and a 30-day drop of 3.16%. Longer-term returns remain healthier, with 3-year TSR at 12.09% and 5-year TSR at 47.87%. The stock shows an indicated intrinsic discount of 44.62% and roughly a 12.28% gap to analyst price targets, prompting questions about whether the pullback reflects value or growth expectations. A bull case rests on steady revenue growth and margin expansion from digitization and new deposit and loan origination systems, potentially lifting net margins. Risks include heavy commercial real estate exposure and higher funding costs that could compress margins longer than anticipated. The analysis pegs a fair value of $73.40, suggesting the shares are undervalued, though the view hinges on earnings and cost dynamics.

NYSE to host MSCI U.S. options, expanding ICE's index-derivatives footprint

January 17, 2026, 9:52 AM EST. NYSE will become the U.S. options venue for MSCI benchmark indexes, with contracts to be listed on NYSE Arca and NYSE American, pending regulatory approval. The move deepens ICE's partnership with MSCI and extends its footprint in index-linked derivatives, complementing ICE's large share of MSCI futures volumes and risk-management tools. Analysts will assess whether U.S.-listed MSCI options materially shift ICE's longer-term growth narrative or mainly reinforce near-term drivers in mortgage-technology integration and fee competition across core trading franchises. ICE's plan to invest up to US$2 billion in Polymarket signals a broader push into digital and prediction-market infrastructure, which could support electronification and data-driven catalysts, but adds regulatory and technology risk. Valuation views remain split, with some seeing upside from index derivatives and others cautious on cyclical energy and commodities exposure.

AstraZeneca Still Sensibly Priced After 31.3% One-Year Gain, DCF Indicates Undervaluation

January 17, 2026, 9:51 AM EST. AZN, AstraZeneca (LSE:AZN), closed at £140.52, down 1.2% in the past week, up 3.7% over 30 days, 3.4% year to date and 31.3% over 12 months. With a broad portfolio and ongoing pipeline, the stock stays in focus as regulatory decisions and milestones shape risk. Simply Wall St assigns a 3/6 valuation score. The piece stresses DCF as a valuation lens: a two-stage Free Cash Flow to Equity model puts an intrinsic value around $253.49 per share, versus the current price, implying roughly a 44.6% discount and an undervalued reading on cash flows. A secondary check uses the P/E framework, noting how growth and risk influence what is "normal."

Robinhood now lists 50 cryptocurrencies for U.S. investors; Bitcoin, Ethereum, Solana among top picks

January 17, 2026, 9:38 AM EST. Robinhood now lists 50 cryptocurrencies for U.S. investors, up from a limited set in the past. The expansion aligns with looser state scrutiny and broader platform policy, though some assets remain restricted in New York or Texas. The roster includes Bitcoin (BTC), Ethereum (ETH), and Solana (SOL) among the most liquid choices, with others ranging from Chainlink (LINK) to Polkadot (DOT) and several niche tokens. The author favors the larger, well-known coins with clearer investment theses. The piece notes that the three best of the bunch are Bitcoin (BTC), Ethereum (ETH), and Solana (SOL), reflecting long-standing market presence and liquidity.

Alight, Inc. slumps 26% in 30 days as revenue headwinds weigh on valuation

January 17, 2026, 9:37 AM EST. Alight, Inc. shares fell 26% in the last 30 days, extending a 12-month decline of about 77%. The stock trades at a P/S ratio near 0.4x, far below the Professional Services group where peers trade above 1.3x. The weak multiple follows shrinking revenue: a 1.9% drop last year and a 25% slide over three years. Six analysts forecast revenue turning negative again, about −0.2% next year, versus industry growth near +6.3%. The P/S gap hints at downside risk if top line does not rebound. While some investors still consider the stock attractively priced, there is no clear floor yet. Market participants will watch upcoming results and whether analysts lift forecasts as revenue trends stabilize.

Brazil stocks shrug off Venezuela attack as inflation cools and rate cuts loom

January 17, 2026, 9:36 AM EST. Brazil's Bovespa rose nearly 1% on Jan. 5 and has climbed about 3% through Friday, as investors shrug off the Venezuela attack. The iShares MSCI Brazil ETF (EWZ) has gained around 3% since the event. Domestic drivers matter: inflation slowed to 4.26% in December, below the 4.5% target, and unemployment sits near a record low. The Selic rate remains at 15% after tightening, with markets eyeing possible rate cuts. Analysts warn easing could clash with a wide fiscal gap, but may attract more foreign money. Traders say the market is pricing inflation relief and policy normalization rather than geopolitics.

Ackman's 39.5% Bet: Amazon, Alphabet and Uber Dominate Pershing Square Portfolio

January 17, 2026, 9:22 AM EST. Pershing Square Capital Management's stock mix centers on three large holdings. Bill Ackman's fund counts Amazon, Alphabet, and Uber Technologies among its largest bets, together making up about 39.5% of the portfolio. A portfolio is the fund's collection of investments. Amazon accounts for roughly 8.7% of the portfolio, spanning e-commerce, cloud, and ads; its prime growth engine is AWS, the cloud unit, and its pursuit of efficiency via automation. Alphabet accounts for about 10.5%, retaining leadership in search while expanding AI features. Uber sits among the top positions, reflecting a bet on ride-hailing and delivery networks. The concentration underscores Ackman's emphasis on large, cash-generating platforms; investors will weigh the risk of a narrow slice of holdings amid macro swings.

Three stocks could soar 40%+ in 2026: Dream Finders Homes, EPR Properties, SoFi Technologies

January 17, 2026, 9:21 AM EST. Three stocks could soar 40% or more in 2026, per a market view tied to rate projections for 2026. The S&P 500 remains near an all-time high, yet opportunities persist. The piece cautions there is no crystal ball for short-term moves, and the outlook depends on market conditions and 2026 rate projections. The stocks highlighted are Dream Finders Homes, EPR Properties, and SoFi Technologies. Prices cited are the morning quotes of Jan. 9, 2026, and the video publication was Jan. 10, 2026. The author discloses holdings in the three names; the disclosure also notes the publisher's positions. The report uses plain language, with brief jargon notes such as CFP (certified financial planner).

Secret formula to ease retirement anxiety as data show bear markets are rarer

January 17, 2026, 9:20 AM EST. Wall Street stress tests for retirees often overstate risk. Ben Carlson of Ritholtz Wealth Management finds bear markets and 40% drawdowns are rarer than headlines imply. Using data back to 1928, a 30% market drop appears in about 10% of years; a 40% drop in about 5%. For a 65-year-old who lives to 85, the odds of a 40% drawdown in that window are small, and portfolio losses can be muted by prudent asset allocation. For example, with a 50% stock exposure, a 40% market decline could trim the nest egg by about 20%, while the rest remains in fixed income such as bonds and treasuries. The piece offers a simple formula to ease retirement anxiety, grounded in the low probability of a catastrophic crash.

Nova (NVMI) valuation under scrutiny after rally

January 17, 2026, 9:08 AM EST. Nova's shares sit at US$445.70 after a run of gains that has driven multi-year returns higher. Seven-day, 30-day and YTD performance are strong, with 1-, 3-, and 5-year gains accelerating investor attention. Valuation checks from Simply Wall St place Nova at a 1/6 value score. In valuation models, the DCF approach, using a 2-stage Free Cash Flow to Equity method, pegs an intrinsic value of $83.32 per share, versus the current price, suggesting the stock is overvalued by about 435%. The P/E stands at 53.94x, above the industry average of 43.37x but below the peer average of 72.44x, implying the stock trades at a premium to the sector yet not far from peers. Overall, rally has challenged traditional value math.

Powell Industries (POWL) Appears Overvalued After Rally, DCF Indicates

January 17, 2026, 9:07 AM EST. Powell Industries (POWL) trades around $419.98 after a sharp rally. In the past week it rose 14.9%, 30 days 32.4%, and it is up 19.1% year-to-date and 61.5% over the last year. Simply Wall St's valuation checklist scores the stock 2/6 for undervaluation. The piece explains a Discounted Cash Flow (DCF) model using a 2-stage Free Cash Flow to Equity approach: latest twelve-month FCF about $155 million, forecast to 2026 of $116.8 million, with projections into 2035 in the $100 million range. The model yields an intrinsic value of about $131.05 per share. At current levels, the price implies roughly a 220% premium to fair value, i.e., the stock appears overvalued. Valuation is only one lens; investors should weigh growth, margins, and macro factors.

NOVONIX valuation tested after Panasonic timing shift to 2027 mass production

January 17, 2026, 9:06 AM EST.NOVONIX (ASX: NVX), updated on its partnership with Panasonic Energy, pushing mass production of synthetic graphite anode material to the second half of 2027, while targeting industrial-grade output this year. The update follows a sharp one-day share drop of 15.84% and a 7-day decline of 24.78%, despite 1-year TSR (total shareholder return) of 37.04% and 5-year TSR of 84.77%. The stock trades at a P/S ratio of 41.3x, well above peers at 4.6x and the broader electronics sector at 1.9x. By contrast, fair-value estimates imply a P/S near 105.7x, hinting at a premium priced for future growth if sentiment shifts. Risks include a 2027 production delay and annual losses of A$66.25 million, which could pressure funding and sentiment.

Stem, Inc. shares jump 29% as revenue slump weighs on valuation (NYSE: STEM)

January 17, 2026, 9:05 AM EST. Stem, Inc. shares have risen 29% in the past month, lifting the year-to-date gain but leaving the company with weak revenue momentum. The stock's P/S ratio sits at 1x, well below many Electrical peers where P/S trades above 2x and some above 6x. Revenue declined 36% in the last year and 37% over three years, per the latest filings. Analysts forecast near-zero growth next year, vs industry growth near 12%. The modest P/S appears to reflect muted growth expectations and sentiment rather than a pure valuation metric. Investors remain cautious about Stem's path to revenue acceleration.

Comfort Systems USA jumps 27% in 30 days as high P/E reflects growth bets

January 17, 2026, 8:52 AM EST. Comfort Systems USA Inc. (NYSE: FIX) has extended its rally, up 27% in the last 30 days and 122% year to date. The stock trades at a P/E of 47.1x, well above the US market's typical levels, prompting questions about its valuation. The high multiple is framed by stronger earnings momentum, with EPS rising about 80% last year and 276% over three years. Eight analysts see EPS growing around 25% next year, versus about 16% for the broader market. Investors appear to price in continued earnings strength, even as the elevated P/E attracts scrutiny. The takeaway: the stock's valuation rests on growth expectations, and a pullback would hinge on a disappointment in the forecast.

Uber's ROCE stabilizes as profitability returns fuel reinvestment

January 17, 2026, 8:51 AM EST. Uber Technologies posted a trailing ROCE of 9.1% for the twelve months to September 2025, roughly in line with the Transportation sector's 9.7% average. The metric uses EBIT divided by (total assets minus current liabilities). The company has moved from loss-making five years ago to profitability, and 129% more capital employed is now being deployed, signaling reinvestment opportunities that could lift returns. Shares have risen about 56% over five years as investors recognize the shift. But the piece flags two warning signs to monitor and notes analysts' forward views are mixed. A detailed analyst report is suggested for Uber. This analysis reflects historical data from Simply Wall St.

Institutional owners hold 71% of Goldman Sachs; Vanguard leads with 9.1% stake

January 17, 2026, 8:50 AM EST. Institutional ownership in Goldman Sachs Group, Inc. (NYSE:GS) remains dominant, with institutions controlling 71% of the shares. The largest single holder is The Vanguard Group, Inc., with a 9.1% stake, followed by the second and third-largest holders at about 7.3% and 6.1%. The top 25 investors together own less than half, pointing to a broad base of smaller holders and no single owner with a majority. Institutions can sway trading and sentiment, given their capital and cross-portfolio influence. Investors should note earnings history and forecasts as analysts offer a range of views. The ownership profile implies meaningful influence from institutions, with potential volatility tied to shifts in institutional sentiment.

General Dynamics' 22% CAGR outpaced earnings growth over the same five-year period

January 17, 2026, 8:34 AM EST. General Dynamics (NYSE: GD) posted a five-year rally of 140%, with an 11% gain in the last three months. Over the same span, EPS grew 7.1% per year, slower than the roughly 19% annual share price advance, suggesting the market priced in improving momentum. Five-year TSR reached about 168%, driven largely by dividends; one-year TSR was 40% including dividends. The five-year annualized TSR sits around 22%. The evidence points to positive sentiment, even as earnings growth trails the price run. Investors may want to review insider activity and the role of the dividends in total returns.

Apple insiders sold $23 million in shares, signaling hesitancy

January 17, 2026, 8:33 AM EST. Apple Inc. insiders, including executives and board members, sold about $23 million of stock over the past year. The largest move was Arthur Levinson selling about $21 million at $232, below the current $256, signaling caution about valuation. The sale accounted for ~2.1% of Levinson's stake. In the last three months, insider Chris Kondo sold $1.0 million, with no reported purchases. Insider ownership sits around $2.5 billion, roughly 0.07% of the company, a sign of significant ownership but modest relative to the market. No insider buys were recorded in the past year, underscoring a cautious posture as Apple grows profits.

Is Robinhood Stock a Buy Now? Bear Market Risks and Valuation

January 17, 2026, 8:17 AM EST. Robinhood shares have fallen about 20% from their all-time high, entering a bear-market mood for the discount broker. Is this a buying opportunity or a trap? Robinhood (HOOD) competes with Charles Schwab and Interactive Brokers as a low-cost, app-driven platform that popularized commission-free trading. It expanded into crypto and recently sports betting, aiming at a younger user base. The stock trades at a lofty P/Emultiple near 50, richer than Schwab's ~24 and Interactive Brokers' ~34, and well above the S&P500 around 31. A broader market lens shows the contrast: the VanguardFinancialsETF trades around 19x earnings. The stock has surged about 1,100% over the last three years, but its customer base has never endured a deep bear market. Investors will weigh valuation against cyclicality and scale.

Analysts keep Wells Fargo forecast steady after mixed full-year results

January 17, 2026, 8:16 AM EST. Wells Fargo & Company (WFC) shares fell 7.9% to $88.38 in the week after the full-year results. Revenue came in at about US$80b, just shy of estimates; statutory EPS was US$6.26. Looking ahead, 19 analysts project 2026 revenue of US$88.6b, about 11% above the prior year, with EPS seen at US$6.99, up around 6.6%. Before the print, forecasts were US$88.4b and US$7.05 for 2026, and analysts left their view largely unchanged. The consensus price target sits at US$100; a range of US$83-US$113 shows divergent views but a cluster around the target. Analysts see growth of about 11% annualized to end-2026, versus 1.8% over the past five years and peers near 8.9%.

Labcorp declares $0.72 dividend; yield ~1.1% (LH)

January 17, 2026, 8:04 AM EST. Labcorp Holdings Inc. (NYSE: LH) will pay a quarterly dividend of $0.72 per share on March 12. The annualized dividend yield is about 1.1% at the current price, below the industry average. The company has a short dividend history-four years-with payments broadly stable. Next year, EPS is forecast to rise about 67.3%, implying a payout ratio around 21% if the trend continues, a level viewed as sustainable. Earnings growth has averaged roughly 3.5% over the last five years, but the dividend track record is not long, so investors should be cautious about relying on dividend income. The outlook hinges on future earnings and payout decisions; two warning signs have been flagged by some analyses.

ATI stock appears overvalued on DCF despite 1-year rally

January 17, 2026, 8:03 AM EST. ATI closed at $124.35, up 117.5% over the last year. A two-stage free cash flow to equity (FCF) model yields an intrinsic value of about $110.94 per share, suggesting the stock is roughly 12% overvalued on a cash-flow basis. The shares trade at a forward P/E of 37.98x, below the Aerospace & Defense industry average of about 42x, offering some valuation cushion despite the rally. Simply Wall St assigns a 2/6 valuation score. The model uses cash flow projections through 2035, with TTM FCF near $446.7 million and longer-term estimates over $900 million. The update underscores ATI's specialty materials and engineered products business and sector demand for advanced alloys. Investors should weigh the DCF signal against growth prospects and market momentum.

Abivax rally driven by pipeline attention; DCF flags overvaluation

January 17, 2026, 8:02 AM EST.Abivax SA rose on stronger biotech-pipeline attention, but a DCF framework flags overvaluation. The stock closed at €102.20, up 3.2% in 7 days and 8.1% in 30 days, with a year-to-date drop of 11.1%. Over the last year and three years the shares have surged as investors priced pipeline potential. Simply Wall St assigns ABVX a valuation score of 0/6. The analysis uses a 2-stage Free Cash Flow to Equity model; the latest twelve-month FCF was a loss of €171.7 million, with forecasts of €18.4 million in 2027. The intrinsic value per share is €31.59, implying the price is about 223% above fair value. Verdict: overvalued on this framework, even as pipeline visibility sustains attention.

Wells Fargo earnings: analysts keep forecasts after mixed full-year results

January 17, 2026, 8:01 AM EST. Wells Fargo & Company posted a mixed full-year report that sent shares down about 7.9% to $88.38 over the week. Revenue was $80 billion, with statutory earnings of $6.26 a share, broadly in line with estimates. Analysts expect 2026 revenue of $88.6 billion, up 11% from 2025, and EPS of $6.99, a 6.6% rise. Prior forecasts had been $88.4 billion and $7.05 per share, suggesting no major shift in outlook after the results. The street kept a $100 price target, with a range from $83 to $113. Growth is expected to accelerate for the bank, to about 11% revenue growth by end-2026, versus roughly 1.8% annualized over the past five years and about 9% for peers. Overall sentiment remains largely unchanged.

Pfizer's ROE underperforms peers as market weighs growth prospects

January 17, 2026, 7:52 AM EST. Pfizer's stock has risen about 4.7% in three months, but a muted ROE (return on equity) raises questions about earnings growth. The trailing-twelve-month ROE is 11% (US$9.8 billion net profit on US$93 billion of equity). That compares with an industry average ROE of 22%. Over five years, Pfizer's net income has fallen about 13%, while the industry grew about 8.6%. The company also has a payout ratio near 88% of profits, leaving roughly 12% to reinvest in growth. Investors should ask whether the market has fully priced in any future earnings expansion; without stronger capital allocation or higher retention, upside may be limited. While vaccines and a pipeline could support value, the near-term path hinges on profitability and efficiency.

Oversold Energy Stocks With RSI Near 30 Eye Near-Term Upside

January 17, 2026, 7:51 AM EST. Three energy names sit with RSI readings below 30, a classic sign of oversold conditions that traders weigh for near-term moves. Delek US Holdings (DK) has had its target trimmed to $38 after JP Morgan's Zach Parham kept a Neutral stance; the shares slipped about 3.8% on Thursday after a 9% slide in the last month and a 52-week low near $11.02. Expand Energy (EXE) remained a Buy with a target cut to $150 from UBS's Josh Silverstein; the stock fell about 1.9% to $99.52, down roughly 7% in a month, trading near a 52-week low of $91.02. XCF Global (SAFX) filed for a large share offering, leaving the stock down about 65% in the past month though it rose 2.8% to $0.14; RSI stood at 21.4.

Financial stocks slide on credit-card rate cap proposal; some see buying opportunity

January 17, 2026, 7:50 AM EST. Financial stocks dipped on news of a proposed one-year, 10% cap on credit-card interest rates, sparking risk-off moves in lenders. Major card issuers fell: Bank of America down about 4.5% week after the proposal; JPMorgan Chase off 6.6%; American Express down 6.8%; Capital One -9.9%; Citigroup -4.8%. Visa shed about 8% and Mastercard nearly 7% as networks declined alongside issuers. The S&P 500 rose earlier in the week but eased, underscoring the gap between headlines and broad markets. Past attempts to cap card rates have stalled in Congress; analysts say a move is unlikely to pass soon, limiting downside risk if the bill remains non-passable. Still, some traders see the sell-off as temporary, with a potential buying opportunity for select financial names if sentiment stabilizes.

Regal Rexnord at US$160: valuation signals limited upside

January 17, 2026, 7:49 AM EST. Regal Rexnord Corp (NYSE: RRX) shares have climbed about 24% over the past two months, trading near its 52-week high. Our valuation puts the stock roughly at fair value, about 8.5% below an estimated intrinsic value of $174.92, implying limited upside if the market has already priced in positives. The name exhibits a high beta, signaling greater price swings than the broader market and possible pullbacks to create a buying opportunity. Next-year earnings are projected to grow about 85%, supporting stronger cash flows but not guaranteeing gains in the stock price. Investors should also weigh the balance sheet and management track record. With the stock around fair value, a deeper dive is warranted before buying on dips rather than chasing near-term gains.

FIGR stock rally triggers valuation questions after sharp surge

January 17, 2026, 7:48 AM EST. Figure Technology Solutions, ticker FIGR, traded near US$73.91 after a sharp rally. The stock rose 27.3% in the past week, 98.2% in 30 days and 69% year to date, fueling questions about upside and risk. Simply Wall St rates its valuation 0/6. Its Excess Returns model estimates an intrinsic value of US$15.17 per share, implying the shares are about 387% above that value and categorizing the stock as overvalued. The firm also notes a Discounted Cash Flow framework and a P/S ratio as additional lenses, especially for companies still building earnings. With market sentiment shifting toward diversified financials, investors should rely on multiple valuation checks rather than a single metric.

Galiano Gold climbs 5.1% after securing US$75 million revolving credit facility

January 17, 2026, 7:47 AM EST. On December 17, 2025, Galiano Gold said its Asanko Gold Mine subsidiary secured a new US$75 million revolving credit facility to support operations in Ghana and bolster liquidity. The facility offers flexibility to fund working capital and future mine development without immediate equity issuance. The liquidity could underpin the next phase of development and finance the Abore drilling program, with about US$3.1 million allocated toward deeper drilling toward a maiden underground resource in the MRMR. Still, the company cautions that returns remain exposed to concentration in a single asset and rising Ghanaian royalties and levies. Forecasts show US$612.9 million revenue and US$157.4 million earnings by 2028. fair value estimates range widely, including a CA$4.80 per-share value implying roughly 23% upside; investors should consider multiple perspectives.

Ampco-Pittsburgh (AP) shares up 118% in 12 months amid mixed earnings and notable insider buying

January 17, 2026, 7:46 AM EST.AP's stock has surged 118% over the past year and 178% in the latest quarter, lifting the three-year TSR to about 82% even as the company posted negative EPS last year. Revenue was broadly flat, suggesting price gains may reflect other factors and market sentiment more than pure earnings growth. The year also featured notable insider buying in the most recent quarter, a potential positive signal. However, the five-year annualized TSR remains negative, around -3%, underscoring a mixed longer-term picture. Investors should weigh earnings quality, cash flow, and risk factors alongside the near-term price move before drawing conclusions about the stock.

Ford Stock Outlook 2026-2030: Earnings Beat, Dividend Yield at 4.41%

January 17, 2026, 7:45 AM EST. Ford Motor Company, traded as F, posted a Q3 2025 earnings beat with EPS of 0.45 and revenue of $47.19 billion, but trimmed full-year guidance after a fire at a major aluminum supplier. The stock has slipped 0.51% in the last month after a 6.13% gain in the prior month, and is up about 38.6% over the past year. It has risen roughly 57% from its one year low on April 8. Ford continues to reward shareholders with a dividend yielding about 4.41% (15 cents per share quarterly). Looking ahead, the debate centers on whether Ford's core ICE lineup and the F-Series can sustain growth amid macro headwinds, supply-chain risk, and evolving auto demand. Analysts offer varied 12-month projections.

Waste Management posts 107% five-year TSR as shares track EPS growth

January 17, 2026, 7:36 AM EST. Waste Management (NYSE:WM) has produced a 107% total shareholder return (TSR) over five years, beating the 59% price-only market gain. The five-year share-price rise stands at about 92%, though the more recent period has been softer, with a 6.1% TSR in the last year. Over the same horizon, earnings per share grew about 12% annually, roughly tracking the 14% annualized price gain, suggesting sentiment hasn't drastically shifted. Insider buying picked up in the last three months, a potential positive signal. The company has delivered an average annual TSR of 16% over five years, underscoring a strong long-run track record, even as near-term pace slows while the growth strategy unfolds.

US stock markets closed for MLK Day 2026; Nasdaq and NYSE reopen Jan. 20

January 17, 2026, 7:35 AM EST. US stock markets will be closed on Monday, Jan. 19, 2026, in observance of MLK Day. The Nasdaq and NYSE will not trade and will reopen with regular hours on Jan. 20. The U.S. bond markets will also be closed on Jan. 19 and reopen Jan. 20, per the Securities Industry and Financial Markets Association. After MLK Day, markets resume normal activity until Presidents Day on Feb. 16. The 2026 holiday schedule also lists other market holidays, including Good Friday (Apr. 3), Memorial Day (May 25), Juneteenth (Jun. 19), Independence Day (Jul. 3), Labor Day (Sept. 7), Thanksgiving (Nov. 26) with early close on Nov. 25, and Christmas (Dec. 25) with early close on Dec. 24.

Vista Gold Corp. AI-generated signals point to long entry near 1.18, stop at 1.17

January 17, 2026, 7:33 AM EST. Vista Gold Corp. shares trade as VGZ:CA with AI-generated signals updated January 17, 2026. The plan for the stock in the long horizon is to buy near 1.18 CAD, with a stop loss at 1.17 to cap downside. No short positions are offered at this time. Ratings for Near, Mid and Long terms appear as Strong, Neutral, and Strong respectively. The note cites a timestamp and author, framing this as a data-driven briefing rather than a price target. A stop loss is a preset price to limit losses; readers should treat it as part of a risk-management framework.

Pacira BioSciences shares fall 28% in a rough month as P/S signals muted growth

January 17, 2026, 7:32 AM EST. Pacira BioSciences Inc. (PCRX) has lost about 28% of its share value over the past month, with a 14% decline in the last year for long-time holders. The stock trades at a price-to-sales (P/S) ratio of 1.1x, well below many US pharmaceutical peers, where P/S often exceeds 4.7x and can top 25x. The low multiple reflects softer revenue growth recently. In the last fiscal year, revenue rose 3.1%; over three years, revenue is up about 9.6%. Six analysts project roughly 8.4% annual revenue growth over the next three years, a pace well short of the industry's ~33% growth. Investors price in limited upside, and the P/S remains muted amid modest top-line momentum.

Tredegar (TG) adds US$27 million to market cap in the past week as five-year struggles persist

January 17, 2026, 7:31 AM EST.Tredegar Corporation (NYSE: TG) added about US$27 million of market value in the past seven days, yet five-year losses cloud the stock narrative. The shares rose about 14% in the latest quarter, but are down roughly 47% over five years, underperforming the market. Total shareholder return (TSR) over five years registered a loss of 41% after dividends. A more recent glide, TSR up about 4.5% over the trailing 12 months, edges above zero but trails the market. Revenue has declined about 7.5% annually; profitability has returned in the last five years, a sign of stabilization perhaps. Investors watch for a rebound, but one warning from analysts remains. Insider buying could provide a spark, if it materializes.

Unifi's debt burden vs. market cap raises dilution risk

January 17, 2026, 7:30 AM EST. Unifi, Inc. (NYSE: UFI) carries debt that may test its balance sheet. As of September 2025, net debt stood at about US$88.6 million, down from US$122.9 million a year earlier, with cash of US$20.6 million. The latest balance sheet shows liabilities of US$65.0 million due within a year and US$118.5 million beyond that, against US$20.6 million in cash and US$83.8 million in near-term receivables. That leaves liabilities about US$79.2 million higher than liquid assets, a gap larger than the company's market capitalization of roughly US$72.2 million. Management may face pressure to raise capital if a quick balance-sheet cleanup is needed, potentially causing dilution for shareholders. Over the past year, revenue declined to US$560 million, and EBIT (earnings before interest and taxes) slipped into a loss.

Procter & Gamble appears undervalued after cash-flow analysis despite share-price weakness

January 17, 2026, 7:14 AM EST. Procter & Gamble traded at $144.53, up 1.9% over 7 days but weaker over 30 days and 1 year. A cash-flow focus points to a value opportunity. A Discounted Cash Flow (DCF) analysis pegs the stock's intrinsic value at about $193.88 per share, implying shares are roughly 25.5% undervalued relative to today's price. The model uses a two-stage Free Cash Flow to Equity framework, anchored by a forward view to 2035 and a latest twelve-month FCF of about $15.4 billion. The piece also flags the P/E ratio as a secondary measure for this mature consumer-staples name, noting growth and earnings risk shape the normal multiple. The stock has logged a -7.9% 12-month return and earns a 4 of 6 value score in the checks.

SpaceX IPO Could Raise Over $30 Billion, But Analysts Warn of Risks

January 17, 2026, 7:13 AM EST. SpaceX aims for a 2026 IPO that could raise more than $30 billion, potentially the largest in history, though the company has yet to file. The plan hinges on its dominance in launch services, Starlink satellite internet and reusable rocket tech, with critics noting the lack of public comparables. Private valuation could hinge on bets for orbital data centers and AI compute, per ARK Invest's Daniel Maguire, who points to SpaceX's decade lead and full reusability as differentiators versus Blue Origin. Veteran IPO scholar Jay Ritter cautions that traditional IPOs skew toward institutional buyers, and that valuation, timing and execution risk could affect returns. Investors should weigh SpaceX's multi-domain growth against a distant, uncertain path to liquidity.

Fairfax Financial slips below 50-day moving average as analysts adjust targets

January 17, 2026, 7:02 AM EST. Fairfax Financial Holdings Limited (TSE:FFH) edged below its 50-day moving average on Friday, trading as low as C$2,436.42 against the line of C$2,463.78. The shares last traded at C$2,436.42 on volume of 119,835. Analysts updated targets across the Street: Raymond James trimmed to C$2,900 from C$3,050; National Bankshares lifted to C$3,200 with an Outperform rating; BMO Capital Markets cut to C$2,600; Scotiabank raised to C$3,050 with an Outperform. MarketBeat shows five Buy ratings and one Hold, with a consensus price of C$2,764.29. Fairfax's market value sits near C$53.91 billion, with a P/E of 11.80 and a P/E/G of 0.27. The company reported C$52.04 EPS and C$17.72 billion revenue in the quarter, with a net margin of 13.90% and ROE of 17.43%.

AI-generated signals show near-term strength for SFI:CA amid no long plans

January 17, 2026, 7:01 AM EST. Solution Financial Inc. (SFI:CA) is in focus as AI-generated signals update January 17. The report shows no long plans at this time. A short near 0.28 is indicated, with a stop-loss at 0.28 and no target provided. The near-term rating is Strong, with mid- and long-term readings listed as Neutral. The update notes a timestamp and points readers to the AI-generated signals page. A chart for SFI:CA accompanies the note, underscoring that the data reflect sentiment rather than guaranteed moves. Readers should treat this as a snapshot of AI-driven guidance rather than a sole basis for trading decisions.

Sarepta Therapeutics looks undervalued after 82% annual drop, supported by a DCF valuation

January 17, 2026, 7:00 AM EST. Shares of Sarepta Therapeutics (SRPT) traded around $21.13 as the year-long decline deepened. The stock is down 11.3% over the past week and 82.1% over 12 months, with only a muted 30-day move. A Simply Wall St valuation review flags DCF as a key driver, showing an intrinsic value of $75.74 per share and a view that the stock is undervalued by about 72% at current prices. The model uses a 2-stage free cash flow to equity approach; the latest twelve-month FCF is a loss of $360.01 million, but projections turn positive to $273.50 million in 2026 and $506 million in 2027, reaching $466 million by 2030. The firm scores 5/6 on valuation checks, underscoring a potential base case for longer-term investors.

Talen Energy: Is TLN Still Attractively Valued After a 58% One-Year Rally?

January 17, 2026, 6:59 AM EST. TLN closed at $371.66, up 0.2% last week, 5.6% in 30 days, -6.3% YTD, and 58.2% over the past year. The stock carries a valuation score of 3/6. A two-stage DCF shows a latest twelve months' free cash flow of about $162.7 million and forecasts $2.532 billion in 2030, with a rise from $1.134 billion in 2026. Discounting to today yields an intrinsic value near $1,281.16 per share, about 71% below the price, implying the stock is undervalued on that model. The P/E ratio is 75.13x, well above the Renewable Energy industry average of 16.94x and higher than peers. Investors weigh the upside implied by the DCF against the high multiple and broader risks.

Is Viasat (VSAT) Still Attractive After a 417% One-Year Surge

January 17, 2026, 6:58 AM EST. Viasat closed at $45.94, up 416.8% in the past year, with 7-day and 30-day gains and a 22.1% YTD rise. The rally coincides with broader attention on satellite connectivity in the US tech sector. Simply Wall St rates VSAT 5/6 for undervaluation. The piece walks through valuation methods: a DCF model using a 2-stage Free Cash Flow to Equity framework yields an intrinsic value of about $117.88 per share and suggests the stock is about 61% undervalued. It also uses a P/S approach for cross-checking. The aim is to align cash-flow prospects with the current price.

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Coca-Cola stock price flatlines into long weekend as KO traders eye Feb. 10 earnings
Previous Story

Coca-Cola stock price flatlines into long weekend as KO traders eye Feb. 10 earnings

Northern Star Resources share price slips after four-day run as NST investors brace for Jan 22 update
Next Story

Northern Star Resources share price slips after four-day run as NST investors brace for Jan 22 update

Go toTop